Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Nuclear Medicine

  Free Subscription


Articles published in Ann Nucl Med

Retrieve available abstracts of 383 articles:
HTML format



Single Articles


    July 2021
  1. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
    Optimization of injection dose in (18)F-FDG PET/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan.
    Ann Nucl Med. 2021 Jul 21. pii: 10.1007/s12149-021-01656.
    PubMed     Abstract available


  2. GALIUTO L, Leccisotti L, Locorotondo G, Porto I, et al
    Coronary plaque instability assessed by positron emission tomography and optical coherence tomography.
    Ann Nucl Med. 2021 Jul 17. pii: 10.1007/s12149-021-01651.
    PubMed     Abstract available


    June 2021
  3. KUYUMCU S, Isik EG, Tiryaki TO, Has-Simsek D, et al
    Prognostic significance of (68)Ga-Pentixafor PET/CT in multiple myeloma recurrence: a comparison to (18)F-FDG PET/CT and laboratory results.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01652.
    PubMed     Abstract available


  4. FASSBIND S, Ferraro DA, Stelmes JJ, Fankhauser CD, et al
    (68)Ga-PSMA-11 PET imaging in patients with ongoing androgen deprivation therapy for advanced prostate cancer.
    Ann Nucl Med. 2021 Jun 29. pii: 10.1007/s12149-021-01646.
    PubMed     Abstract available


  5. OZTURK BC, Atahan E, Gencer A, Harbiyeli DO, et al
    Investigation of perfusion defects by Q-SPECT/CT in patients with mild-to-moderate course of COVID-19 and low clinical probability for pulmonary embolism.
    Ann Nucl Med. 2021 Jun 25. pii: 10.1007/s12149-021-01647.
    PubMed     Abstract available


  6. KARLS S, Gold R, Kravets S, Wang Y, et al
    Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
    Ann Nucl Med. 2021 Jun 19. pii: 10.1007/s12149-021-01642.
    PubMed     Abstract available


  7. KAUSHIK P, Patel C, Gulati GS, Seth S, et al
    Comparison of (68)Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis.
    Ann Nucl Med. 2021 Jun 14. pii: 10.1007/s12149-021-01641.
    PubMed     Abstract available


  8. LEE SW, Jeong SY, Kim K, Kim SJ, et al
    Direct comparison of F-18 FDG PET/CT and MRI to predict pathologic response to neoadjuvant treatment in locally advanced rectal cancer: a meta-analysis.
    Ann Nucl Med. 2021 Jun 10. pii: 10.1007/s12149-021-01639.
    PubMed     Abstract available


  9. KARAHAN SEN NP, Aksu A, Capa Kaya G
    A different overview of staging PET/CT images in patients with esophageal cancer: the role of textural analysis with machine learning methods.
    Ann Nucl Med. 2021 Jun 9. pii: 10.1007/s12149-021-01638.
    PubMed     Abstract available


  10. IKOMA Y, Takuwa H, Nishino A, Maeda J, et al
    Measurement of changes in endogenous serotonin level by positron emission tomography with [(18)F]altanserin.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01633.
    PubMed     Abstract available


  11. LI Y, Li Y, Huang Y, Wu X, et al
    Usefulness of (18)F-FDG PET/CT in treatment-naive patients with thymic squamous cell carcinoma.
    Ann Nucl Med. 2021 Jun 8. pii: 10.1007/s12149-021-01640.
    PubMed     Abstract available


  12. LUO R, Wang L, Ye F, Wang YR, et al
    [(18)F]FEDAC translocator protein positron emission tomography-computed tomography for early detection of mitochondrial dysfunction secondary to myocardial ischemia.
    Ann Nucl Med. 2021 Jun 3. pii: 10.1007/s12149-021-01630.
    PubMed     Abstract available


  13. NI YC, Tseng FP, Pai MC, Hsiao IT, et al
    Detection of Alzheimer's disease using ECD SPECT images by transfer learning from FDG PET.
    Ann Nucl Med. 2021 Jun 2. pii: 10.1007/s12149-021-01626.
    PubMed     Abstract available


    May 2021
  14. EVANGELISTA L, Zucchetta P, Moletta L, Serafini S, et al
    The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review.
    Ann Nucl Med. 2021 May 28. pii: 10.1007/s12149-021-01629.
    PubMed     Abstract available


  15. OTANI T, Otsuka H, Matsushita K, Otomi Y, et al
    Effect of different examination conditions on image quality and quantitative value of amyloid positron emission tomography using (18)F-flutemetamol.
    Ann Nucl Med. 2021 May 27. pii: 10.1007/s12149-021-01634.
    PubMed     Abstract available


  16. ICHIKAWA H, Kawakami K, Onoguchi M, Shibutani T, et al
    Automatic quantification package (Hone Graph) for phantom-based image quality assessment in bone SPECT: computerized automatic classification of detectability.
    Ann Nucl Med. 2021 May 24. pii: 10.1007/s12149-021-01631.
    PubMed     Abstract available


  17. TERESINSKA A, Wozniak O, Maciag A, Wnuk J, et al
    Quality and utility of [(123)I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.
    Ann Nucl Med. 2021 May 23. pii: 10.1007/s12149-021-01628.
    PubMed     Abstract available


  18. HUNG GU, Zou J, He Z, Zhang X, et al
    Left-ventricular dyssynchrony in viable myocardium by myocardial perfusion SPECT is predictive of mechanical response to CRT.
    Ann Nucl Med. 2021 May 21. pii: 10.1007/s12149-021-01632.
    PubMed     Abstract available


  19. KIM M, Gu W, Nakajima T, Higuchi T, et al
    Texture analysis of [(18)F]-fluorodeoxyglucose-positron emission tomography/computed tomography for predicting the treatment response of postoperative recurrent or metastatic oral squamous cell carcinoma treated with cetuximab.
    Ann Nucl Med. 2021 May 20. pii: 10.1007/s12149-021-01623.
    PubMed     Abstract available


  20. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
    Focal severe decrease in myocardial technetium-99 m sestamibi uptake indicates ventricular irreversibility in patients with dilated cardiomyopathy.
    Ann Nucl Med. 2021 May 18. pii: 10.1007/s12149-021-01625.
    PubMed     Abstract available


  21. ASA S, Sonmezoglu K, Uslu-Besli L, Sahin OE, et al
    Evaluation of F-18 DOPA PET/CT in the detection of recurrent or metastatic medullary thyroid carcinoma: comparison with GA-68 DOTA-TATE PET/CT.
    Ann Nucl Med. 2021 May 15. pii: 10.1007/s12149-021-01627.
    PubMed     Abstract available


  22. HOTTA M, Minamimoto R, Gohda Y, Miwa K, et al
    Prognostic value of (18)F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.
    Ann Nucl Med. 2021 May 4. pii: 10.1007/s12149-021-01622.
    PubMed     Abstract available


  23. KOMEK H, Can C, Guzel Y, Oruc Z, et al
    (68)Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 May 2. pii: 10.1007/s12149-021-01616.
    PubMed     Abstract available


    April 2021
  24. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
    Associations of frontal QRS-T angle with left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
    Ann Nucl Med. 2021 Apr 18. pii: 10.1007/s12149-021-01596.
    PubMed     Abstract available


  25. HOU Y, Guo K, Fan X, Shang K, et al
    Crossed cerebellar diaschisis: risk factors and prognostic value in focal cortical dysplasia by (18)F-FDG PET/CT.
    Ann Nucl Med. 2021 Apr 11. pii: 10.1007/s12149-021-01613.
    PubMed     Abstract available


  26. HASHIMOTO F, Ito M, Ote K, Isobe T, et al
    Deep learning-based attenuation correction for brain PET with various radiotracers.
    Ann Nucl Med. 2021 Apr 3. pii: 10.1007/s12149-021-01611.
    PubMed     Abstract available


    March 2021
  27. SATOH Y, Imai M, Hirata K, Asakawa Y, et al
    Optimal relaxation parameters of dynamic row-action maximum likelihood algorithm and post-smoothing filter for image reconstruction of dedicated breast PET.
    Ann Nucl Med. 2021 Mar 27. pii: 10.1007/s12149-021-01604.
    PubMed     Abstract available


  28. ZIMMERMANN PA, Houdu B, Cesaire L, Nakouri I, et al
    Revisiting detection of in-transit metastases in melanoma patients using digital (18)F-FDG PET/CT with small-voxel reconstruction.
    Ann Nucl Med. 2021 Mar 26. pii: 10.1007/s12149-021-01608.
    PubMed     Abstract available


  29. SCOBIOALA S, Kittel C, Wolters H, Huss S, et al
    Diagnostic efficiency of hybrid imaging using PSMA ligands, PET/CT, PET/MRI and MRI in identifying malignant prostate lesions.
    Ann Nucl Med. 2021 Mar 19. pii: 10.1007/s12149-021-01606.
    PubMed     Abstract available


  30. HE J, Wang Q, Zhang Y, Wu H, et al
    Preoperative prediction of regional lymph node metastasis of colorectal cancer based on (18)F-FDG PET/CT and machine learning.
    Ann Nucl Med. 2021 Mar 18. pii: 10.1007/s12149-021-01605.
    PubMed     Abstract available


  31. MA G, Liu C, Lian W, Zhang Y, et al
    (18)F-FLT PET/CT imaging for early monitoring response to CDK4/6 inhibitor therapy in triple negative breast cancer.
    Ann Nucl Med. 2021 Mar 10. pii: 10.1007/s12149-021-01603.
    PubMed     Abstract available


  32. SAKAGUCHI K, Kaida H, Yoshida S, Ishii K, et al
    Attenuation correction using deep learning for brain perfusion SPECT images.
    Ann Nucl Med. 2021 Mar 9. pii: 10.1007/s12149-021-01600.
    PubMed     Abstract available


  33. WATABE T, Uemura M, Soeda F, Naka S, et al
    High detection rate in [(18)F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients.
    Ann Nucl Med. 2021 Mar 4. pii: 10.1007/s12149-021-01602.
    PubMed     Abstract available


  34. KAWANO M, Tsuchiya J, Bae H, Kimura K, et al
    Phase I clinical study of NMB58, a novel positron emission tomography (PET)-myocardial perfusion imaging tracer, conducted to evaluate its safety and pharmacokinetics in Japanese healthy adult males.
    Ann Nucl Med. 2021 Mar 1. pii: 10.1007/s12149-021-01601.
    PubMed     Abstract available


    February 2021
  35. KITAMURA Y, Baba S, Isoda T, Maruoka Y, et al
    (123)I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.
    Ann Nucl Med. 2021 Feb 14. pii: 10.1007/s12149-021-01595.
    PubMed     Abstract available


  36. YILDIRIM OA, Gundogan C, Can C, Poyraz K, et al
    Correlations between whole body volumetric parameters of (68)Ga-PSMA PET/CT and biochemical-histopathological parameters in castration-naive and resistant prostate cancer patients.
    Ann Nucl Med. 2021 Feb 14. pii: 10.1007/s12149-021-01594.
    PubMed     Abstract available


  37. KATO A, Nakamoto Y, Ishimori T, Hayakawa N, et al
    Diagnostic performance of (68)Ga-DOTATOC PET/CT in tumor-induced osteomalacia.
    Ann Nucl Med. 2021 Feb 13. pii: 10.1007/s12149-021-01575.
    PubMed     Abstract available


  38. PACE L, Nicolai E, Cavaliere C, Basso L, et al
    Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Ann Nucl Med. 2021 Feb 11. pii: 10.1007/s12149-021-01590.
    PubMed     Abstract available


  39. YOON H, Ha S, Kwon SJ, Park SY, et al
    Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
    Ann Nucl Med. 2021 Feb 8. pii: 10.1007/s12149-021-01586.
    PubMed     Abstract available


  40. ALBERTS I, Sachpekidis C, Prenosil G, Viscione M, et al
    Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT.
    Ann Nucl Med. 2021 Feb 7. pii: 10.1007/s12149-021-01588.
    PubMed     Abstract available


  41. JAMSEK J, Hocevar M, Bergant D, Zaletel K, et al
    Diagnostic value of [(18)F]Fluorocholine PET/CT in detection of primary medullary thyroid cancer.
    Ann Nucl Med. 2021 Feb 5. pii: 10.1007/s12149-021-01579.
    PubMed     Abstract available


  42. PENG L, Hong X, Yuan Q, Lu L, et al
    Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
    Ann Nucl Med. 2021 Feb 4. pii: 10.1007/s12149-021-01585.
    PubMed     Abstract available


  43. KONG Z, Zhang Y, Liu D, Liu P, et al
    Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
    Ann Nucl Med. 2021 Feb 2. pii: 10.1007/s12149-021-01589.
    PubMed     Abstract available


    January 2021
  44. CRIMI F, Valeggia S, Baffoni L, Stramare R, et al
    [18F]FDG PET/MRI in rectal cancer.
    Ann Nucl Med. 2021 Jan 31. pii: 10.1007/s12149-021-01580.
    PubMed     Abstract available


  45. ITO H, Kubo H, Takahashi K, Nishijima KI, et al
    Integrated PET/MRI scanner with oxygen-15 labeled gases for quantification of cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen.
    Ann Nucl Med. 2021 Jan 27. pii: 10.1007/s12149-021-01578.
    PubMed     Abstract available


  46. SATOH Y, Kawamoto M, Kubota K, Murakami K, et al
    Clinical practice guidelines for high-resolution breast PET, 2019 edition.
    Ann Nucl Med. 2021 Jan 25. pii: 10.1007/s12149-021-01582.
    PubMed     Abstract available


  47. MACCORA D, Caldarella C, Calcagni ML
    (11)C-Methionine PET/CT in patients with primary hyperparathyroidism and inconclusive pre-operative imaging work-up: diagnostic accuracy and role of semi-quantitative analysis.
    Ann Nucl Med. 2021 Jan 24. pii: 10.1007/s12149-021-01584.
    PubMed     Abstract available


  48. HAN S, Kim YI, Woo S, Kim TH, et al
    Prognostic and predictive values of interim (18)F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2021 Jan 20. pii: 10.1007/s12149-021-01583.
    PubMed     Abstract available


  49. LIU J, Yang X, Yang J
    Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of (18)F-FDG PET/CT in newly diagnosed secondary hemophagocytic lymphohistiocytosis.
    Ann Nucl Med. 2021 Jan 19. pii: 10.1007/s12149-021-01577.
    PubMed     Abstract available


  50. ZHANG W, Xu S, Yu H, Li X, et al
    Radioactive synthesis of tau PET imaging agent (18)F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis.
    Ann Nucl Med. 2021 Jan 18. pii: 10.1007/s12149-020-01566.
    PubMed     Abstract available


  51. KONISHI T, Shibutani T, Okuda K, Yoneyama H, et al
    Metal artifact reduction for improving quantitative SPECT/CT imaging.
    Ann Nucl Med. 2021 Jan 18. pii: 10.1007/s12149-020-01560.
    PubMed     Abstract available


  52. CRIMI F, Borsetto D, Stramare R, Di Carlo R, et al
    [(18)F]FDG PET/MRI versus contrast-enhanced MRI in detecting regional HNSCC metastases.
    Ann Nucl Med. 2021 Jan 17. pii: 10.1007/s12149-020-01565.
    PubMed     Abstract available


  53. KANG SY, Moon BS, Kim HO, Yoon HJ, et al
    The impact of data-driven respiratory gating in clinical F-18 FDG PET/CT: comparison of free breathing and deep-expiration breath-hold CT protocol.
    Ann Nucl Med. 2021 Jan 15. pii: 10.1007/s12149-020-01574.
    PubMed     Abstract available


  54. ZAMORA E, Valdivia AY
    Oncologic significance of unexpected osseous foci on FDG-PET without correlative CT abnormalities.
    Ann Nucl Med. 2021 Jan 13. pii: 10.1007/s12149-020-01572.
    PubMed     Abstract available


  55. SHIMIZU Y, Nakai Y, Iikuni S, Watanabe H, et al
    Synthesis and evaluation of gallium-68-labeled nitroimidazole-based imaging probes for PET diagnosis of tumor hypoxia.
    Ann Nucl Med. 2021 Jan 9. pii: 10.1007/s12149-020-01573.
    PubMed     Abstract available


  56. SHIGENO T, Kozaka T, Kitamura Y, Ogawa K, et al
    In vitro and in vivo evaluation of [(125/123)I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([(125/123)I]-OI5V) as a potential sigma-1 receptor ligand for SPECT.
    Ann Nucl Med. 2021 Jan 8. pii: 10.1007/s12149-020-01552.
    PubMed     Abstract available


  57. HAS SIMSEK D, Isik EG, Engin MN, Kuyumcu S, et al
    Somatostatin receptor-positive breast lesions on (68)Ga-DOTATATE PET/CT.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01570.
    PubMed     Abstract available


  58. YAMANE T, Fukushima K, Shirotake S, Nishimoto K, et al
    Test-retest repeatability of quantitative bone SPECT/CT.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01568.
    PubMed     Abstract available


  59. BRESSER PL, Vorster M, Sathekge MM
    An overview of the developments and potential applications of (68)Ga-labelled PET/CT hypoxia imaging.
    Ann Nucl Med. 2021 Jan 5. pii: 10.1007/s12149-020-01563.
    PubMed     Abstract available


  60. OHBA M, Kobayashi R, Kirii K, Fujita K, et al
    Comparison of Alzheimer's disease patients and healthy controls in the easy Z-score imaging system with differential image reconstruction methods using SPECT/CT: verification using normal database of our institution.
    Ann Nucl Med. 2021 Jan 4. pii: 10.1007/s12149-020-01562.
    PubMed     Abstract available


  61. CHENG JL, Hsu CC, Wang PW, Sung KC, et al
    The feasibility of anterior 180 degrees (99m) Tc-sestamibi parathyroid SPECT/CT.
    Ann Nucl Med. 2021 Jan 3. pii: 10.1007/s12149-020-01553.
    PubMed     Abstract available


  62. MORI H, Taki J, Wakabayashi H, Hiromasa T, et al
    Colchicine treatment early after infarction attenuates myocardial inflammatory response demonstrated by (14)C-methionine imaging and subsequent ventricular remodeling by quantitative gated SPECT.
    Ann Nucl Med. 2021 Jan 3. pii: 10.1007/s12149-020-01559.
    PubMed     Abstract available


  63. NISHII R, Saga T, Sudo H, Togawa T, et al
    Clinical value of PET/CT with carbon-11 4DST in the evaluation of malignant and benign lung tumors.
    Ann Nucl Med. 2021 Jan 2. pii: 10.1007/s12149-020-01554.
    PubMed     Abstract available


  64. SON HJ, Oh JS, Oh M, Lee SJ, et al
    Test-retest reproducibility of dopamine transporter density measured with [(18)F]FP-CIT PET in patients with essential tremor and Parkinson's disease.
    Ann Nucl Med. 2021 Jan 2. pii: 10.1007/s12149-020-01561.
    PubMed     Abstract available


    November 2020
  65. ARABI H, Zaidi H
    Non-local mean denoising using multiple PET reconstructions.
    Ann Nucl Med. 2020 Nov 26. pii: 10.1007/s12149-020-01550.
    PubMed     Abstract available


  66. ATTARWALA AA, Hardiansyah D, Romano C, Jimenez-Franco LD, et al
    Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for (99m)Tc imaging.
    Ann Nucl Med. 2020 Nov 12. pii: 10.1007/s12149-020-01547.
    PubMed     Abstract available


  67. INUBUSHI M, Miura H, Kuji I, Ito K, et al
    Current status of radioligand therapy and positron-emission tomography with prostate-specific membrane antigen.
    Ann Nucl Med. 2020 Nov 11. pii: 10.1007/s12149-020-01549.
    PubMed     Abstract available


  68. DERLIN T, Schultze-Florey C, Werner RA, Mohn N, et al
    (18)F-FDG PET/CT of off-target lymphoid organs in CD19-targeting chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma.
    Ann Nucl Med. 2020 Nov 11. pii: 10.1007/s12149-020-01544.
    PubMed     Abstract available


  69. SAID MA, Musarudin M, Zulkaffli NF
    The quantification of PET-CT radiotracers to determine minimal scan time using quadratic formulation.
    Ann Nucl Med. 2020 Nov 3. pii: 10.1007/s12149-020-01543.
    PubMed     Abstract available


    October 2020
  70. ANNUNZIATA S, Pelliccioni A, Hohaus S, Maiolo E, et al
    The prognostic role of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: a pilot study application of neural networks to predict time-to-event.
    Ann Nucl Med. 2020 Oct 22. pii: 10.1007/s12149-020-01542.
    PubMed     Abstract available


  71. SEBAN RD, Assie JB, Giroux-Leprieur E, Massiani MA, et al
    FDG-PET biomarkers associated with long-term benefit from first-line immunotherapy in patients with advanced non-small cell lung cancer.
    Ann Nucl Med. 2020 Oct 18. pii: 10.1007/s12149-020-01539.
    PubMed     Abstract available


  72. HANAFY OS, Khalil MM, Khater IM, Mohammed HS, et al
    Development of a new Python-based cardiac phantom for myocardial SPECT imaging.
    Ann Nucl Med. 2020 Oct 17. pii: 10.1007/s12149-020-01534.
    PubMed     Abstract available


  73. JIANG C, Teng Y, Chen J, Wang Z, et al
    Value of (18)F-FDG PET/CT for prognostic stratification in patients with primary intestinal diffuse large B cell lymphoma treated with an R-CHOP-like regimen.
    Ann Nucl Med. 2020 Oct 15. pii: 10.1007/s12149-020-01536.
    PubMed     Abstract available


  74. CHAKRAVARTY R, Shetty P, Nair KVV, Rajeswari A, et al
    Reactor produced [(64)Cu]CuCl2 as a PET radiopharmaceutical for cancer imaging: from radiochemistry laboratory to nuclear medicine clinic.
    Ann Nucl Med. 2020 Oct 13. pii: 10.1007/s12149-020-01522.
    PubMed     Abstract available


  75. HAN S, Oh JS, Kim JS
    Immune microenvironment of the gene signature reflecting the standardised uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma.
    Ann Nucl Med. 2020 Oct 12. pii: 10.1007/s12149-020-01537.
    PubMed     Abstract available


  76. KANNO M, Tsujikawa T, Narita N, Ito Y, et al
    Comparison of diagnostic accuracy between [(18)F]FDG PET/MRI and contrast-enhanced MRI in T staging for oral tongue cancer.
    Ann Nucl Med. 2020 Oct 10. pii: 10.1007/s12149-020-01526.
    PubMed     Abstract available


  77. KUBOTA K, Tanaka N, Miyata Y, Ohtsu H, et al
    Comparison of (18)F-FDG PET/CT and (67)Ga-SPECT for the diagnosis of fever of unknown origin: a multicenter prospective study in Japan.
    Ann Nucl Med. 2020 Oct 9. pii: 10.1007/s12149-020-01533.
    PubMed     Abstract available


  78. ZHAO P, Yu T, Pan Z
    Prognostic value of the baseline 18F-FDG PET/CT metabolic tumour volume (MTV) and further stratification in low-intermediate (L-I) and high-intermediate (H-I) risk NCCNIPI subgroup by MTV in DLBCL MTV predict prognosis in DLBCL.
    Ann Nucl Med. 2020 Oct 1. pii: 10.1007/s12149-020-01531.
    PubMed     Abstract available


    September 2020
  79. NOMURA M, Toyama H, Suzuki H, Yamada T, et al
    Peripheral benzodiazepine receptor/18 kDa translocator protein positron emission tomography imaging in a rat model of acute brain injury.
    Ann Nucl Med. 2020 Sep 28. pii: 10.1007/s12149-020-01530.
    PubMed     Abstract available


  80. KURISU S, Nitta K, Watanabe N, Ikenaga H, et al
    Effects of upright T-wave in lead aVR on left ventricular volume and function derived from ECG-gated SPECT in patients with advanced chronic kidney disease.
    Ann Nucl Med. 2020 Sep 27. pii: 10.1007/s12149-020-01528.
    PubMed     Abstract available


  81. KANGASMAA T, Hippelainen E, Constable C, Turunen S, et al
    Quantitative Monte Carlo-based brain dopamine transporter SPECT imaging.
    Ann Nucl Med. 2020 Sep 25. pii: 10.1007/s12149-020-01532.
    PubMed     Abstract available


  82. CAGLAR M, Tuncel M, Yildiz E, Karabulut E, et al
    Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
    Ann Nucl Med. 2020 Sep 25. pii: 10.1007/s12149-020-01529.
    PubMed     Abstract available


  83. KIM HO, Kim BS, Kang SY, Bang JI, et al
    Metabolic changes in breast cancer on dual-time-point (18)F-FDG PET/CT imaging according to primary tumor uptake and background parenchymal enhancement.
    Ann Nucl Med. 2020 Sep 24. pii: 10.1007/s12149-020-01525.
    PubMed     Abstract available


  84. AOKI Y, Nakayama M, Nomura K, Tomita Y, et al
    The utility of a deep learning-based algorithm for bone scintigraphy in patient with prostate cancer.
    Ann Nucl Med. 2020 Sep 21. pii: 10.1007/s12149-020-01524.
    PubMed     Abstract available


  85. SENDA M
    Standardization of PET imaging and site qualification program by JSNM: collaboration with EANM/EARL.
    Ann Nucl Med. 2020 Sep 16. pii: 10.1007/s12149-020-01518.
    PubMed    


  86. PRIETO PRIETO JC, Vallejo Casas JA, Hatzimichael E, Fotopoulos A, et al
    The contribution of metabolic parameters of FDG PET/CT prior and during therapy of adult patients with lymphomas.
    Ann Nucl Med. 2020 Sep 13. pii: 10.1007/s12149-020-01521.
    PubMed     Abstract available


  87. ISHII S, Sugawara S, Yaginuma Y, Kobiyama H, et al
    Causes of false negatives in technetium-99 m methoxyisobutylisonitrile scintigraphy for hyperparathyroidism: influence of size and cysts in parathyroid lesions.
    Ann Nucl Med. 2020 Sep 12. pii: 10.1007/s12149-020-01520.
    PubMed     Abstract available


  88. MANABE O, Naya M, Aikawa T, Tamaki N, et al
    Recent advances in cardiac positron emission tomography for quantitative perfusion analyses and molecular imaging.
    Ann Nucl Med. 2020 Sep 11. pii: 10.1007/s12149-020-01519.
    PubMed     Abstract available


  89. YAMAZAKI K, Nishii R, Maeda T, Makishima H, et al
    Assessment of SPECT-CT fusion images and semi-quantitative evaluation using SUV in (123)I-IMP SPECT in patients with choroidal melanoma.
    Ann Nucl Med. 2020 Sep 9. pii: 10.1007/s12149-020-01517.
    PubMed     Abstract available


    August 2020
  90. ISHII K, Yamada T, Hanaoka K, Kaida H, et al
    Regional gray matter-dedicated SUVR with 3D-MRI detects positive amyloid deposits in equivocal amyloid PET images.
    Ann Nucl Med. 2020 Aug 27. pii: 10.1007/s12149-020-01513.
    PubMed     Abstract available


  91. ABE K, Hosono M, Igarashi T, Iimori T, et al
    The 2020 national diagnostic reference levels for nuclear medicine in Japan.
    Ann Nucl Med. 2020 Aug 27. pii: 10.1007/s12149-020-01512.
    PubMed     Abstract available


  92. PAPANDRIANOS N, Papageorgiou EI, Anagnostis A
    Development of Convolutional Neural Networks to identify bone metastasis for prostate cancer patients in bone scintigraphy.
    Ann Nucl Med. 2020 Aug 24. pii: 10.1007/s12149-020-01510.
    PubMed     Abstract available


  93. NISHIMORI M, Yoshimatsu R, Iwasa H, Miyatake K, et al
    Evaluation of pleural lesions after pleurodesis with OK-432 by fluorodeoxyglucose-positron emission tomography/CT.
    Ann Nucl Med. 2020 Aug 18. pii: 10.1007/s12149-020-01508.
    PubMed     Abstract available


  94. EVANGELISTA L, Ravelli I, Magnani F, Iacobone M, et al
    (18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature.
    Ann Nucl Med. 2020 Aug 7. pii: 10.1007/s12149-020-01507.
    PubMed     Abstract available


  95. MATSUSAKA Y, Nakahara T, Takahashi K, Iwabuchi Y, et al
    Development of (68)Ga-labeled tin colloids for evaluating phagocytic function of Kupffer cells using preclinical PET imaging.
    Ann Nucl Med. 2020 Aug 4. pii: 10.1007/s12149-020-01505.
    PubMed     Abstract available


    July 2020
  96. NOVIKOV SN, Krzhivitskii PI, Kanaev SV, Berlev IV, et al
    SPECT-CT visualization and biopsy of sentinel lymph nodes in patients with stage IAB-IIA cervical cancer.
    Ann Nucl Med. 2020 Jul 15. pii: 10.1007/s12149-020-01503.
    PubMed     Abstract available


  97. MIWA K, Wagatsuma K, Nemoto R, Masubuchi M, et al
    Detection of sub-centimeter lesions using digital TOF-PET/CT system combined with Bayesian penalized likelihood reconstruction algorithm.
    Ann Nucl Med. 2020 Jul 4. pii: 10.1007/s12149-020-01500.
    PubMed     Abstract available


  98. TSUTSUI Y, Awamoto S, Himuro K, Kato T, et al
    Evaluating and comparing the image quality and quantification accuracy of SiPM-PET/CT and PMT-PET/CT.
    Ann Nucl Med. 2020 Jul 3. pii: 10.1007/s12149-020-01496.
    PubMed     Abstract available


    June 2020
  99. CHEN LC, Hung HF, Jong BH, Lin SC, et al
    A method to measure the extent of myocardial ischemia and steal with SPECT myocardial blood flow quantitation.
    Ann Nucl Med. 2020 Jun 30. pii: 10.1007/s12149-020-01493.
    PubMed     Abstract available


  100. TUNCEL M, Kilickap S, Suslu N
    Clinical impact of (68)Ga-DOTATATE PET-CT imaging in patients with medullary thyroid cancer.
    Ann Nucl Med. 2020 Jun 29. pii: 10.1007/s12149-020-01494.
    PubMed     Abstract available


  101. ZHANG Y, Li B, Wu B, Yu H, et al
    Diagnostic performance of whole-body bone scintigraphy in combination with SPECT/CT for detection of bone metastases.
    Ann Nucl Med. 2020 Jun 24. pii: 10.1007/s12149-020-01488.
    PubMed     Abstract available


  102. KUCHARCZAK F, Suau M, Strauss O, Ben Bouallegue F, et al
    Brain (18)F-FDG PET analysis via interval-valued reconstruction: proof of concept for Alzheimer's disease diagnosis.
    Ann Nucl Med. 2020 Jun 23. pii: 10.1007/s12149-020-01490.
    PubMed     Abstract available


  103. WANG Q, Song D, Ma X, Wu X, et al
    Preclinical PET imaging study of lung cancer with (64)CuCl2.
    Ann Nucl Med. 2020 Jun 21. pii: 10.1007/s12149-020-01491.
    PubMed     Abstract available


  104. KOJIMA I, Takanami K, Ogawa T, Sakamoto M, et al
    High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma.
    Ann Nucl Med. 2020 Jun 20. pii: 10.1007/s12149-020-01489.
    PubMed     Abstract available


  105. SHIMOKAWA N, Akamatsu G, Kadosaki M, Sasaki M, et al
    Feasibility study of a PET-only amyloid quantification method: a comparison with visual interpretation.
    Ann Nucl Med. 2020 Jun 13. pii: 10.1007/s12149-020-01486.
    PubMed     Abstract available


  106. KHAW TH, Raynor WY, Borja AJ, Al-Zaghal A, et al
    Assessing the effects of body weight on subchondral bone formation with quantitative (18)F-sodium fluoride PET.
    Ann Nucl Med. 2020 Jun 10. pii: 10.1007/s12149-020-01482.
    PubMed     Abstract available


  107. BELGE G, Bilgin C, Ozkaya G, Kandemirli SG, et al
    Prognostic value of pretreatment tumor-to-blood standardized uptake ratio (SUR) in rectal cancer.
    Ann Nucl Med. 2020;34:432-440.
    PubMed     Abstract available


  108. ONAL C, Torun N, Oymak E, Guler OC, et al
    Retrospective correlation of (68)ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy.
    Ann Nucl Med. 2020;34:388-396.
    PubMed     Abstract available


    May 2020
  109. OLDAN JD, Glaubiger SA, Khandani AH, Jewells VL, et al
    Detectable size of melanoma metastases to brain on PET/CT.
    Ann Nucl Med. 2020 May 25. pii: 10.1007/s12149-020-01481.
    PubMed     Abstract available


  110. SOHARA K, Kiriyama T, Mizumura S, Ishiwata A, et al
    Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chan
    Ann Nucl Med. 2020 May 24. pii: 10.1007/s12149-020-01477.
    PubMed     Abstract available


  111. CHEN YH, Chen HT, Lee MC, Liu SH, et al
    Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Ann Nucl Med. 2020 May 20. pii: 10.1007/s12149-020-01479.
    PubMed     Abstract available


  112. SENA Y, Matsumoto S, Silman C, Otsuka K, et al
    Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET/CT.
    Ann Nucl Med. 2020 May 19. pii: 10.1007/s12149-020-01480.
    PubMed     Abstract available


  113. SIMSEK DH, Sanli Y, Civan C, Engin MN, et al
    Does bone scintigraphy still have a role in the era of 68 Ga-PSMA PET/CT in prostate cancer?
    Ann Nucl Med. 2020 May 11. pii: 10.1007/s12149-020-01474.
    PubMed     Abstract available


  114. HARA S, Kudo T, Hayashi S, Inaji M, et al
    Improvement in cognitive decline after indirect bypass surgery in adult moyamoya disease: implication of (15)O-gas positron emission tomography.
    Ann Nucl Med. 2020 May 6. pii: 10.1007/s12149-020-01473.
    PubMed     Abstract available


  115. SUGAWARA S, Ishii S, Kojima Y, Ito H, et al
    Feasibility of gamma camera-based GFR measurement using renal depth evaluated by lateral scan of (99m)Tc-DTPA renography.
    Ann Nucl Med. 2020;34:349-357.
    PubMed     Abstract available


  116. THIENTUNYAKIT T, Sethanandha C, Muangpaisan W, Chawalparit O, et al
    Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease.
    Ann Nucl Med. 2020;34:337-348.
    PubMed     Abstract available


  117. HU B, Chen W, Zhang Y, Shi H, et al
    (18)F-FDG maximum standard uptake value predicts PD-L1 expression on tumor cells or tumor-infiltrating immune cells in non-small cell lung cancer.
    Ann Nucl Med. 2020;34:322-328.
    PubMed     Abstract available


    April 2020
  118. KIMURA Y, Watanabe A, Yamada T, Watanabe S, et al
    AI approach of cycle-consistent generative adversarial networks to synthesize PET images to train computer-aided diagnosis algorithm for dementia.
    Ann Nucl Med. 2020 Apr 20. pii: 10.1007/s12149-020-01468.
    PubMed     Abstract available


  119. WANG L, Xiong C, Li M, Zeng X, et al
    Assessment of lung glucose uptake in patients with systemic lupus erythematosus pulmonary arterial hypertension: a quantitative FDG-PET imaging study.
    Ann Nucl Med. 2020 Apr 20. pii: 10.1007/s12149-020-01461.
    PubMed     Abstract available


  120. SAKAMOTO F, Shiraishi S, Ogasawara K, Tsuda N, et al
    A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Ann Nucl Med. 2020 Apr 16. pii: 10.1007/s12149-020-01464.
    PubMed     Abstract available


  121. SERAJ SM, Raynor WY, Revheim ME, Al-Zaghal A, et al
    Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients.
    Ann Nucl Med. 2020 Apr 10. pii: 10.1007/s12149-020-01463.
    PubMed     Abstract available


  122. SU W, Ren S, Zhu X, Zhang H, et al
    Standardized thresholds of volume-based PET/CT parameters predicting survival of patients with pancreatic head cancer treated with stereotactic body radiation therapy.
    Ann Nucl Med. 2020 Apr 10. pii: 10.1007/s12149-020-01454.
    PubMed     Abstract available


  123. GOETZ TI, Lang EW, Prante O, Maier A, et al
    Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent (177)Lu-DOTATOC therapy.
    Ann Nucl Med. 2020;34:244-253.
    PubMed     Abstract available


  124. BAEK MS, Cho H, Ryu YH, Lyoo CH, et al
    Customized FreeSurfer-based brain atlas for diffeomorphic anatomical registration through exponentiated lie algebra tool.
    Ann Nucl Med. 2020;34:280-288.
    PubMed     Abstract available


  125. HUANG J, Wu J, Zhao L, Liu W, et al
    Quantitative evaluation of salivary gland scintigraphy in Sjogren's syndrome: comparison of diagnostic efficacy and relationship with pathological features of the salivary glands.
    Ann Nucl Med. 2020;34:289-298.
    PubMed     Abstract available


  126. TAJRA JBM, Calegaro JU, de Paula AP, Bachour D, et al
    Accuracy of Oral (67)Gallium Citrate Scintigraphy in assessment of inflammatory activity of Crohn's disease.
    Ann Nucl Med. 2020;34:263-271.
    PubMed     Abstract available


  127. RICCI M, Chiaravalloti A, Martorana A, Koch G, et al
    The role of epsilon phenotype in brain glucose consumption in Alzheimer's disease.
    Ann Nucl Med. 2020;34:254-262.
    PubMed     Abstract available


    March 2020
  128. ITO K
    Toyama H, Li Y, Hatazawa J, Huang G, Kubota K (eds): PET/CT for inflammatory diseases: basic sciences, typical cases, and review : Singapore: Springer Nature Singapore Pte Ltd., 2020, 233 pages, Hardcover, 169.99 euro.
    Ann Nucl Med. 2020 Mar 28. pii: 10.1007/s12149-020-01459.
    PubMed    


  129. NISHIZAWA S, Kojima S, Okada H, Shinke T, et al
    Ten-year prospective evaluation of whole-body cancer screening with multiple modalities including [(18)F]fluorodeoxyglucose positron emission tomography in a healthy population.
    Ann Nucl Med. 2020 Mar 21. pii: 10.1007/s12149-020-01456.
    PubMed     Abstract available


  130. GIANNAKOU S, Angelidis G, Tsougos I, Valotassiou V, et al
    Pet tracers for vulnerable plaque imaging.
    Ann Nucl Med. 2020 Mar 20. pii: 10.1007/s12149-020-01458.
    PubMed     Abstract available


  131. ONISHI Y, Ito K, Motoi N, Morita T, et al
    Ciliated muconodular papillary tumor of the lung: 18F-FDG PET/CT findings of 15 cases.
    Ann Nucl Med. 2020 Mar 14. pii: 10.1007/s12149-020-01457.
    PubMed     Abstract available


  132. MAHENDRA I, Hanaoka H, Yamaguchi A, Amartuvshin T, et al
    Diagnosis of bladder cancer using (18)F-labeled alpha-methyl-phenylalanine tracers in a mouse model.
    Ann Nucl Med. 2020 Mar 6. pii: 10.1007/s12149-020-01452.
    PubMed     Abstract available


  133. MUGIKURA S, Mori N, Kikuchi H, Mori E, et al
    Relationship between decreased cerebral blood flow and amnesia after microsurgery for anterior communicating artery aneurysm.
    Ann Nucl Med. 2020;34:220-227.
    PubMed     Abstract available


  134. ROMANOV V, Isohashi K, Alobthani G, Beshr R, et al
    Evaluation of the total distribution volume of (18)F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling.
    Ann Nucl Med. 2020;34:155-162.
    PubMed     Abstract available


    February 2020
  135. LI Y, Wu X, Huang Y, Bian D, et al
    (18)F-FDG PET/CT in lung adenosquamous carcinoma and its correlation with clinicopathological features and prognosis.
    Ann Nucl Med. 2020 Feb 22. pii: 10.1007/s12149-020-01450.
    PubMed     Abstract available


  136. LI Y, Wang Q, Wang X, Li X, et al
    Expert Consensus on clinical application of FDG PET/CT in infection and inflammation.
    Ann Nucl Med. 2020 Feb 21. pii: 10.1007/s12149-020-01449.
    PubMed     Abstract available


  137. KURITA Y, Ichikawa Y, Nakanishi T, Tomita Y, et al
    The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on (18)F-FDG PET/CT: comparison with ordered subset expectation maximization reconstruction incorporating time-of-flight model and poin
    Ann Nucl Med. 2020 Feb 14. pii: 10.1007/s12149-020-01446.
    PubMed     Abstract available


  138. CICONE F, Carideo L, Scaringi C, Minniti G, et al
    Reply to Zaragori et al.: "Is IDH mutation status associated with (18)F-FDopa PET uptake".
    Ann Nucl Med. 2020 Feb 4. pii: 10.1007/s12149-020-01443.
    PubMed    


  139. SHARMA A, Okada DR, Yacoub H, Chrispin J, et al
    Diagnosis of cardiac sarcoidosis: an era of paradigm shift.
    Ann Nucl Med. 2020;34:87-93.
    PubMed     Abstract available


  140. OKADA Y, Kato T, Iwata K, Kimura Y, et al
    Evaluation of PiB visual interpretation with CSF Abeta and longitudinal SUVR in J-ADNI study.
    Ann Nucl Med. 2020;34:108-118.
    PubMed     Abstract available


  141. YAMADA T, Watanabe S, Nagaoka T, Nemoto M, et al
    Automatic delineation algorithm of reference region for amyloid imaging based on kinetics.
    Ann Nucl Med. 2020;34:102-107.
    PubMed     Abstract available


    January 2020
  142. ZARAGORI T, Guedj E, Verger A
    Is IDH mutation status associated with (18)F-FDopa PET uptake?
    Ann Nucl Med. 2020 Jan 30. pii: 10.1007/s12149-020-01442.
    PubMed    


  143. MATSUDA H, Uehara T, Okazawa H, Mizumura S, et al
    Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
    Ann Nucl Med. 2020 Jan 27. pii: 10.1007/s12149-020-01439.
    PubMed     Abstract available


  144. TAKANAMI K, Saito M, Matsumoto Y, Sugimura K, et al
    Clinical implication of myocardial FDG uptake pattern in oncologic PET: retrospective comparison study with stress myocardial perfusion imaging as the reference standard.
    Ann Nucl Med. 2020 Jan 24. pii: 10.1007/s12149-020-01437.
    PubMed     Abstract available


  145. KOIZUMI M, Motegi K, Koyama M, Ishiyama M, et al
    Diagnostic performance of a computer-assisted diagnostic system: sensitivity of BONENAVI for bone scintigraphy in patients with disseminated skeletal metastasis is not so high.
    Ann Nucl Med. 2020 Jan 22. pii: 10.1007/s12149-020-01435.
    PubMed     Abstract available


  146. SUN Y, Liu C, Chen Z, Li B, et al
    Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of (99m)Tc-TRODAT-1 SPECT to detect Parkinson's disease.
    Ann Nucl Med. 2020 Jan 10. pii: 10.1007/s12149-019-01434.
    PubMed     Abstract available


  147. WITKOWSKA-PATENA E, Budzynska A, Gizewska A, Dziuk M, et al
    Ordered subset expectation maximisation vs Bayesian penalised likelihood reconstruction algorithm in 18F-PSMA-1007 PET/CT.
    Ann Nucl Med. 2020 Jan 4. pii: 10.1007/s12149-019-01433.
    PubMed     Abstract available


  148. YAMAMOTO Y, Mitsunaga S, Horikawa A, Hino A, et al
    Quantitative bone scan imaging using BSI and BUV: an approach to evaluate ARONJ early.
    Ann Nucl Med. 2020;34:74-79.
    PubMed     Abstract available


  149. SASAKI Y
    Nuclear oncology as seen by me in Japan: a historical review and future perspective.
    Ann Nucl Med. 2020;34:1-12.
    PubMed     Abstract available


  150. LIN YC, Chou FI, Yang BH, Chang CW, et al
    Similar T/N ratio between (18)F-FBPA diagnostic and BPA therapeutic dosages for boron neutron capture therapy in orthotropic tongue cancer model.
    Ann Nucl Med. 2020;34:58-64.
    PubMed     Abstract available


  151. MOHD ROHANI MF, Mat Nawi N, Shamim SE, Wan Sohaimi WF, et al
    Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Ann Nucl Med. 2020;34:39-48.
    PubMed     Abstract available


  152. FUJIWARA K, Tsuji AB, Sudo H, Sugyo A, et al
    (111)In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.
    Ann Nucl Med. 2020;34:13-23.
    PubMed     Abstract available


    December 2019
  153. ZHOU C, Foster B, Hagge R, Foster C, et al
    Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with (18)F-FDG PET/CT muscle metrics.
    Ann Nucl Med. 2019 Dec 10. pii: 10.1007/s12149-019-01429.
    PubMed     Abstract available


  154. OKUYAMA C, Higashi T, Nakamoto R, Ishizu K, et al
    Predominance and homogeneity patterns of physiological FDG accumulation in thoracic and lumbar vertebrae: suspected mechanism of "bone pseudometastasis" on FDG-PET in Japanese patients with esophageal cancer.
    Ann Nucl Med. 2019 Dec 9. pii: 10.1007/s12149-019-01430.
    PubMed     Abstract available


  155. CAN C, Komek H
    Contribution of 5th minute and 2nd hour images to standard imaging in ((68)Ga)PSMA 11 PET/CT.
    Ann Nucl Med. 2019 Dec 5. pii: 10.1007/s12149-019-01428.
    PubMed     Abstract available


    November 2019
  156. ALBANO D, Tomasini D, Bonu M, Giubbini R, et al
    (18)F-Fluciclovine ((18)F-FACBC) PET/CT or PET/MRI in gliomas/glioblastomas.
    Ann Nucl Med. 2019 Nov 26. pii: 10.1007/s12149-019-01426.
    PubMed     Abstract available


  157. HUANG K, Feng Y, Liu D, Liang W, et al
    Quantification evaluation of (99m)Tc-MDP concentration in the lumbar spine with SPECT/CT: compare with bone mineral density.
    Ann Nucl Med. 2019 Nov 25. pii: 10.1007/s12149-019-01425.
    PubMed     Abstract available


  158. SATOH Y, Motosugi U, Imai M, Onishi H, et al
    Comparison of dedicated breast positron emission tomography and whole-body positron emission tomography/computed tomography images: a common phantom study.
    Ann Nucl Med. 2019 Nov 25. pii: 10.1007/s12149-019-01422.
    PubMed     Abstract available


  159. WATANABE M, Nakamoto Y, Ishimori T, Saga T, et al
    Prognostic utility of FDG PET/CT in advanced ovarian, fallopian and primary peritoneal high-grade serous cancer patients before and after neoadjuvant chemotherapy.
    Ann Nucl Med. 2019 Nov 25. pii: 10.1007/s12149-019-01424.
    PubMed     Abstract available


  160. LECCISOTTI L, Manfrida S, Barone R, Ripani D, et al
    The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
    Ann Nucl Med. 2019 Nov 14. pii: 10.1007/s12149-019-01416.
    PubMed     Abstract available


  161. ISHIYAMA M, Relyea-Chew A, Longstreth WT, Lewis DH, et al
    Impact of decompressive craniectomy on brain perfusion scintigraphy as an ancillary test for brain death diagnosis.
    Ann Nucl Med. 2019;33:842-847.
    PubMed     Abstract available


  162. YAMAZAKI T, Inui Y, Ichihara T, Uno M, et al
    Clinical utility of the normal database of (123)I-iodoamphetamine brain perfusion single photon emission computed tomography for statistical analysis using computed tomography-based attenuation correction: a multicenter study.
    Ann Nucl Med. 2019;33:835-841.
    PubMed     Abstract available


  163. FUKUDA Y, Yamamoto Y, Mitamura K, Ishikawa R, et al
    4'-[methyl-(11)C]-thiothymidine as a proliferation imaging tracer for detection of colorectal cancer: comparison with (18)F-FDG.
    Ann Nucl Med. 2019;33:822-827.
    PubMed     Abstract available


    October 2019
  164. KOYASU S, Nishio M, Isoda H, Nakamoto Y, et al
    Usefulness of gradient tree boosting for predicting histological subtype and EGFR mutation status of non-small cell lung cancer on (18)F FDG-PET/CT.
    Ann Nucl Med. 2019 Oct 28. pii: 10.1007/s12149-019-01414.
    PubMed     Abstract available


  165. SUN Y, Liu C, Chen Z, Li B, et al
    A phase 2, open-label, multi-center study to evaluate the efficacy and safety of (99m)Tc-TRODAT-1 SPECT to detect Parkinson's disease.
    Ann Nucl Med. 2019 Oct 23. pii: 10.1007/s12149-019-01412.
    PubMed     Abstract available


  166. LI J, Zheng N, Zhang G, Bao B, et al
    Experimental study on "ischemic memory" of myocardium with different ischemic degrees by (18)F-FDG PET/CT.
    Ann Nucl Med. 2019 Oct 21. pii: 10.1007/s12149-019-01411.
    PubMed     Abstract available


  167. PELLEGRINO S, Fonti R, Mazziotti E, Piccin L, et al
    Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer.
    Ann Nucl Med. 2019 Oct 14. pii: 10.1007/s12149-019-01407.
    PubMed     Abstract available


  168. IKOMA Y, Kimura Y, Yamada M, Obata T, et al
    Correction of head movement by frame-to-frame image realignment for receptor imaging in positron emission tomography studies with [(11)C]raclopride and [(11)C]FLB 457.
    Ann Nucl Med. 2019 Oct 11. pii: 10.1007/s12149-019-01405.
    PubMed     Abstract available


  169. PLOUZNIKOFF N, Artigas C, Sideris S, Martinez Chanza N, et al
    Evaluation of PSMA expression changes on PET/CT before and after initiation of novel antiandrogen drugs (enzalutamide or abiraterone) in metastatic castration-resistant prostate cancer patients.
    Ann Nucl Med. 2019 Oct 5. pii: 10.1007/s12149-019-01404.
    PubMed     Abstract available


  170. CHOI HJ, Jacene H, Kim CK
    No delayed imaging or CCK administration is needed in most cases when bowel excretion does not occur but gallbladder fills promptly.
    Ann Nucl Med. 2019;33:740-745.
    PubMed     Abstract available


  171. PALANGKA CRAP, Hanaoka H, Yamaguchi A, Murakami T, et al
    Al(18)F-labeled alpha-melanocyte-stimulating hormone (alpha-MSH) peptide derivative for the early detection of melanoma.
    Ann Nucl Med. 2019;33:733-739.
    PubMed     Abstract available


    September 2019
  172. FUJIMOTO K, Norikane T, Yamamoto Y, Takami Y, et al
    Association between carotid (18)F-NaF and (18)F-FDG uptake on PET/CT with ischemic vascular brain disease on MRI in patients with carotid artery disease.
    Ann Nucl Med. 2019 Sep 30. pii: 10.1007/s12149-019-01403.
    PubMed     Abstract available


  173. ALVANDI M, Shaghaghi Z, Aryafar V, Fariba F, et al
    The evaluation of left ventricular dyssynchrony in hypertensive patients with a preserved systolic function undergoing gated SPECT myocardial perfusion imaging.
    Ann Nucl Med. 2019 Sep 25. pii: 10.1007/s12149-019-01402.
    PubMed     Abstract available


  174. SCHMIDKONZ C, Goetz TI, Kuwert T, Ritt P, et al
    PSMA SPECT/CT with (99m)Tc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels.
    Ann Nucl Med. 2019 Sep 9. pii: 10.1007/s12149-019-01400.
    PubMed     Abstract available


  175. ELFARRA FG, Calin MA, Parasca SV
    Computer-aided detection of bone metastasis in bone scintigraphy images using parallelepiped classification method.
    Ann Nucl Med. 2019 Sep 6. pii: 10.1007/s12149-019-01399.
    PubMed     Abstract available


  176. ACAR E, Ozdogan O, Aksu A, Derebek E, et al
    The use of molecular volumetric parameters for the evaluation of Lu-177 PSMA I&T therapy response and survival.
    Ann Nucl Med. 2019;33:681-688.
    PubMed     Abstract available


  177. OTOMI Y, Otsuka H, Terazawa K, Kondo M, et al
    A reduced liver (18)F-FDG uptake may be related to hypoalbuminemia in patients with malnutrition.
    Ann Nucl Med. 2019;33:689-696.
    PubMed     Abstract available


    August 2019
  178. KAMEYAMA M, Ishibash K, Wagatsuma K, Toyohara J, et al
    A pitfall of white matter reference regions used in [(18)F] florbetapir PET: a consideration of kinetics.
    Ann Nucl Med. 2019 Aug 27. pii: 10.1007/s12149-019-01397.
    PubMed     Abstract available


  179. OKAMOTO S, Toyonaga T, Matsuzawa K, Aizawa M, et al
    Effect of drugs containing glucose on FDG-PET image quality.
    Ann Nucl Med. 2019 Aug 12. pii: 10.1007/s12149-019-01394.
    PubMed     Abstract available


  180. ANNOVAZZI A, Anelli V, Zoccali C, Rumi N, et al
    (18)F-FDG PET/CT in the evaluation of cartilaginous bone neoplasms: the added value of tumor grading.
    Ann Nucl Med. 2019 Aug 8. pii: 10.1007/s12149-019-01392.
    PubMed     Abstract available


  181. CHEN X, Zhang X, Du M, Dong C, et al
    In vivo preclinical PET/CT imaging of carbon-11-labeled aminoglycerol probe for the diagnosis of liver fibrosis.
    Ann Nucl Med. 2019 Aug 6. pii: 10.1007/s12149-019-01391.
    PubMed     Abstract available


  182. NAKANO M, Nakamura T, Takita Y, Uenaka K, et al
    Radiation dosimetry and pharmacokinetics of florbetapir ((18)F) in Japanese subjects.
    Ann Nucl Med. 2019;33:639-645.
    PubMed    


  183. TAUTY A, Noblet V, Paillard C, Fornecker LM, et al
    Evaluation of the effects of chemotherapy on brain glucose metabolism in children with Hodgkin's lymphoma.
    Ann Nucl Med. 2019;33:564-569.
    PubMed     Abstract available


  184. YILMAZ U, Komek H, Can C, Altindag S, et al
    The role of ((68)Ga)PSMA I&T in biochemical recurrence after radical prostatectomy: detection rate and the correlation between the level of PSA, Gleason score, and the SUVmax.
    Ann Nucl Med. 2019;33:545-553.
    PubMed     Abstract available


    July 2019
  185. OGURA I, Kobayashi E, Nakahara K, Igarashi K, et al
    Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ann Nucl Med. 2019 Jul 24. pii: 10.1007/s12149-019-01390.
    PubMed     Abstract available


  186. SCHMIDKONZ C, Cordes M, Goetz TI, Prante O, et al
    68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Ann Nucl Med. 2019 Jul 23. pii: 10.1007/s12149-019-01387.
    PubMed     Abstract available


  187. INAKI A, Nakajima K, Wakabayashi H, Mochizuki T, et al
    Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
    Ann Nucl Med. 2019 Jul 17. pii: 10.1007/s12149-019-01386.
    PubMed     Abstract available


  188. BARNA S, Garai I, Kukuts K, Gesztelyi R, et al
    Clinical utility of SPECT/CT and CT-dacryocystography-enhanced dacryoscintigraphy in the imaging of lacrimal drainage system obstruction.
    Ann Nucl Med. 2019 Jul 16. pii: 10.1007/s12149-019-01385.
    PubMed     Abstract available


  189. GOTZ TI, Schmidkonz C, Lang EW, Maier A, et al
    Factors affecting accuracy of S values and determination of time-integrated activity in clinical Lu-177 dosimetry.
    Ann Nucl Med. 2019;33:521-531.
    PubMed     Abstract available


  190. OKUYAMA C, Nakajima K, Nakamura S, Nishimura T, et al
    The difference of risk factors predicting cardiac events in patients with chronic kidney disease between with and without diabetes.
    Ann Nucl Med. 2019;33:532-540.
    PubMed     Abstract available


  191. KOIZUMI M, Motegi K, Umeda T
    A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients.
    Ann Nucl Med. 2019;33:502-511.
    PubMed     Abstract available


  192. ABDEL GAWAD H, Khalil MM, W Shafaa M, Al Ramlawy S, et al
    Development of anatomically and lesion contrast-guided partial volume correction: new 3D formalisms and validation in phantom and clinical studies.
    Ann Nucl Med. 2019;33:481-494.
    PubMed     Abstract available


    June 2019
  193. ZANONI L, Varani S, Attard L, Morigi JJ, et al
    18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy.
    Ann Nucl Med. 2019 Jun 28. pii: 10.1007/s12149-019-01381.
    PubMed     Abstract available


  194. NISHIYAMA Y, Kinuya S, Kato T, Kayano D, et al
    Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017.
    Ann Nucl Med. 2019 Jun 24. pii: 10.1007/s12149-019-01382.
    PubMed     Abstract available


  195. CHEN YH, Lue KH, Chu SC, Chang BS, et al
    Combining the radiomic features and traditional parameters of (18)F-FDG PET with clinical profiles to improve prognostic stratification in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    Ann Nucl Med. 2019 Jun 19. pii: 10.1007/s12149-019-01380.
    PubMed     Abstract available


  196. KIM D, Yoon HJ, Woo SH, Lee WJ, et al
    Development of visual scoring system with Tc-99m DMSA renal scintigraphy to predict the risk of recurrence of symptomatic urinary tract infections in pediatric patients.
    Ann Nucl Med. 2019 Jun 18. pii: 10.1007/s12149-019-01379.
    PubMed     Abstract available


  197. IMPERIALE A, Averous G, Helali M, Taieb D, et al
    Limited role of carbidopa-assisted (18)F-FDOPA PET/CT in patients with sporadic non-functional gastroduodenal neuroendocrine neoplasms.
    Ann Nucl Med. 2019 Jun 15. pii: 10.1007/s12149-019-01378.
    PubMed     Abstract available


  198. OUYANG ML, Xia HW, Xu MM, Lin J, et al
    Prediction of occult lymph node metastasis using SUV, volumetric parameters and intratumoral heterogeneity of the primary tumor in T1-2N0M0 lung cancer patients staged by PET/CT.
    Ann Nucl Med. 2019 Jun 10. pii: 10.1007/s12149-019-01375.
    PubMed     Abstract available


  199. WU X, Huang Y, Li Y, Wang Q, et al
    (18)F-FDG PET/CT imaging in pulmonary sarcomatoid carcinoma and correlation with clinical and genetic findings.
    Ann Nucl Med. 2019 Jun 5. pii: 10.1007/s12149-019-01374.
    PubMed     Abstract available


  200. KUBIK T, Kaluzynski K, Burger C, Passeri A, et al
    Novel 3D heart left ventricle muscle segmentation method for PET-gated protocol and its verification.
    Ann Nucl Med. 2019 Jun 1. pii: 10.1007/s12149-019-01373.
    PubMed     Abstract available


  201. ROBERTS G, Lloyd JJ, Petrides GS, Donaghy PC, et al
    (123)I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults.
    Ann Nucl Med. 2019;33:434-443.
    PubMed     Abstract available


  202. TAGO T, Toyohara J, Harada R, Furumoto S, et al
    Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site.
    Ann Nucl Med. 2019;33:375-382.
    PubMed     Abstract available


    May 2019
  203. MEYER AR, Carducci MA, Denmeade SR, Markowski MC, et al
    Improved identification of patients with oligometastatic clear cell renal cell carcinoma with PSMA-targeted (18)F-DCFPyL PET/CT.
    Ann Nucl Med. 2019 May 30. pii: 10.1007/s12149-019-01371.
    PubMed     Abstract available


  204. ZOGALA D, Rucka D, Ptacnik V, Cerny V, et al
    How to recognize stent graft infection after endovascular aortic repair: the utility of 18F-FDG PET/CT in an infrequent but serious clinical setting.
    Ann Nucl Med. 2019 May 29. pii: 10.1007/s12149-019-01370.
    PubMed     Abstract available


  205. DIETEMANN S, Nkoulou R
    Amyloid PET imaging in cardiac amyloidosis: a pilot study using (18)F-flutemetamol positron emission tomography.
    Ann Nucl Med. 2019 May 28. pii: 10.1007/s12149-019-01372.
    PubMed     Abstract available


  206. HAYASHI T, Mishina M, Sakamaki M, Sakamoto Y, et al
    Effect of brain atrophy in quantitative analysis of (123)I-ioflupane SPECT.
    Ann Nucl Med. 2019 May 28. pii: 10.1007/s12149-019-01367.
    PubMed     Abstract available


  207. TAKENAKA A, Inui Y, Kimura Y, Miyake C, et al
    Microliter-ordered automatic blood sampling system for fully quantitative analysis of small-animal PET.
    Ann Nucl Med. 2019 May 22. pii: 10.1007/s12149-019-01368.
    PubMed     Abstract available


  208. SAKAGUCHI R, Kataoka M, Kanao S, Miyake KK, et al
    Distribution pattern of FDG uptake using ring-type dedicated breast PET in comparison to whole-body PET/CT scanning in invasive breast cancer.
    Ann Nucl Med. 2019 May 21. pii: 10.1007/s12149-019-01364.
    PubMed     Abstract available


  209. WESTERGAARD-NIELSEN M, Rohde M, Godballe C, Eriksen JG, et al
    Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.
    Ann Nucl Med. 2019 May 17. pii: 10.1007/s12149-019-01362.
    PubMed     Abstract available


  210. OKUYAMA C, Matsushima S, Nishimura M, Yamada K, et al
    Increased (18)F-FDG accumulation in the tonsils after chemotherapy for pediatric lymphoma: a common physiological phenomenon.
    Ann Nucl Med. 2019;33:368-373.
    PubMed     Abstract available


    April 2019
  211. MIZUMURA S, Iwabuchi S, Fujita S, Harashina J, et al
    Measurement of cerebral vascular reserves with I-123 IMP SPECT without an arterial input function using the microsphere model and radiopharmaceutical dose calibration.
    Ann Nucl Med. 2019 Apr 13. pii: 10.1007/s12149-019-01336.
    PubMed     Abstract available


  212. HAY B, Mariano-Goulart D, Bourdon A, Benkiran M, et al
    Diagnostic performance of (18)F-FDG PET-CT for large vessel involvement assessment in patients with suspected giant cell arteritis and negative temporal artery biopsy.
    Ann Nucl Med. 2019 Apr 11. pii: 10.1007/s12149-019-01358.
    PubMed     Abstract available


  213. HIRATA M, Yao T, Fujimura S, Kanai Y, et al
    Development of a p38alpha-selective radioactive probe for qualitative diagnosis of cancer using SPECT.
    Ann Nucl Med. 2019 Apr 5. pii: 10.1007/s12149-019-01341.
    PubMed     Abstract available


  214. CHIARAVALLOTI A, Esposito V, Ursini F, Di Giorgio E, et al
    Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [(18)F] FDOPA PET a prognostic factor in these patients?
    Ann Nucl Med. 2019 Apr 4. pii: 10.1007/s12149-019-01355.
    PubMed     Abstract available


  215. ALBANO D, Re A, Tucci A, Giubbini R, et al
    Prognostic role of DeltaMTV and DeltaTLG in Burkitt lymphoma.
    Ann Nucl Med. 2019;33:280-287.
    PubMed     Abstract available


  216. CICONE F, Carideo L, Scaringi C, Arcella A, et al
    (18)F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma.
    Ann Nucl Med. 2019;33:295-302.
    PubMed     Abstract available


  217. ISHIZAKI A, Mishiro K, Shiba K, Hanaoka H, et al
    Fundamental study of radiogallium-labeled aspartic acid peptides introducing octreotate derivatives.
    Ann Nucl Med. 2019;33:244-251.
    PubMed     Abstract available


  218. ROPPONGI M, Izumisawa M, Terasaki K, Muraki Y, et al
    (18)F-FDG and (11)C-choline uptake in proliferating tumor cells is dependent on the cell cycle in vitro.
    Ann Nucl Med. 2019;33:237-243.
    PubMed     Abstract available


    March 2019
  219. ALBANO D, Bosio G, Bianchetti N, Pagani C, et al
    Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in mantle cell lymphoma.
    Ann Nucl Med. 2019 Mar 30. pii: 10.1007/s12149-019-01354.
    PubMed     Abstract available


  220. INOMATA T, Watanuki S, Odagiri H, Nambu T, et al
    A systematic performance evaluation of head motion correction techniques for 3 commercial PET scanners using a reproducible experimental acquisition protocol.
    Ann Nucl Med. 2019 Mar 29. pii: 10.1007/s12149-019-01353.
    PubMed     Abstract available


  221. SHINYA T, Otomi Y, Kubo M, Kinoshita M, et al
    Preliminary clinical assessment of dynamic (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study.
    Ann Nucl Med. 2019 Mar 25. pii: 10.1007/s12149-019-01350.
    PubMed     Abstract available


  222. HANDA SS, Baba S, Yamashita K, Nishizaka M, et al
    The severity of obstructive sleep apnea syndrome cannot predict the accumulation of brain amyloid by imaging with [11C]-Pittsburgh compound B PET computed tomography in patients with a normal cognitive function.
    Ann Nucl Med. 2019 Mar 18. pii: 10.1007/s12149-019-01349.
    PubMed     Abstract available


  223. SHEIKHBAHAEI S, Jones KM, Werner RA, Salas-Fragomeni RA, et al
    (18)F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies.
    Ann Nucl Med. 2019 Mar 15. pii: 10.1007/s12149-019-01343.
    PubMed     Abstract available


  224. KHAWAR A, Eppard E, Roesch F, Ahmadzadehfar H, et al
    Preliminary results of biodistribution and dosimetric analysis of [(68)Ga]Ga-DOTA(ZOL): a new zoledronate-based bisphosphonate for PET/CT diagnosis of bone diseases.
    Ann Nucl Med. 2019 Mar 15. pii: 10.1007/s12149-019-01348.
    PubMed     Abstract available


  225. VITOR T, Kozasa EH, Bressan RA, Lacerda SS, et al
    Impaired brain dopamine transporter in chemobrain patients submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1.
    Ann Nucl Med. 2019 Mar 7. pii: 10.1007/s12149-019-01331.
    PubMed     Abstract available


  226. KOIZUMI M, Koyama M
    Comparison between single photon emission computed tomography with computed tomography and planar scintigraphy in sentinel node biopsy in breast cancer patients.
    Ann Nucl Med. 2019;33:160-168.
    PubMed     Abstract available


    February 2019
  227. AOKI M, Watabe T, Nagamori S, Naka S, et al
    Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
    Ann Nucl Med. 2019 Feb 28. pii: 10.1007/s12149-019-01346.
    PubMed     Abstract available


  228. ISHIWATA K
    4-Borono-2-(18)F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research.
    Ann Nucl Med. 2019 Feb 28. pii: 10.1007/s12149-019-01347.
    PubMed     Abstract available


  229. UEBERROTH BE, Lawhorn-Crews JM, Heilbrun LK, Smith DW, et al
    The use of 3'-deoxy-3'-(18)F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy.
    Ann Nucl Med. 2019 Feb 27. pii: 10.1007/s12149-019-01345.
    PubMed     Abstract available


  230. AYDIN AM, Haberal B, Artykov M, Bilen CY, et al
    Clinicopathological predictors of positive (68)Ga-PSMA-11 PET/CT in PSA-only recurrence of localized prostate cancer following definitive therapy.
    Ann Nucl Med. 2019 Feb 18. pii: 10.1007/s12149-019-01340.
    PubMed     Abstract available


  231. BRITO AET, Mourato FA, de Oliveira RPM, Leal ALG, et al
    Evaluation of whole-body tumor burden with (68)Ga-PSMA PET/CT in the biochemical recurrence of prostate cancer.
    Ann Nucl Med. 2019 Feb 11. pii: 10.1007/s12149-019-01342.
    PubMed     Abstract available


  232. YAMAMOTO H, Takemoto S, Maebatake A, Karube S, et al
    Verification of image quality and quantification in whole-body positron emission tomography with continuous bed motion.
    Ann Nucl Med. 2019 Feb 1. pii: 10.1007/s12149-019-01334.
    PubMed     Abstract available


    January 2019
  233. KORTELAINEN MJ, Koivumaki TM, Vauhkonen MJ, Hakulinen MA, et al
    Effect of respiratory motion on cardiac defect contrast in myocardial perfusion SPECT: a physical phantom study.
    Ann Nucl Med. 2019 Jan 24. pii: 10.1007/s12149-019-01335.
    PubMed     Abstract available


  234. SILMAN C, Matsumoto S, Ono A, Kiyonaga M, et al
    18F-FDG uptake in the normal appendix in adults: PET/CT evaluation.
    Ann Nucl Med. 2019 Jan 16. pii: 10.1007/s12149-019-01330.
    PubMed     Abstract available


  235. MATHIS DT, Buel L, Rasch H, Amsler F, et al
    Distribution of bone tracer uptake in symptomatic knees after ACL reconstruction compared to asymptomatic non-operated knees: a method for better differentiating patient-specific from disease-specific bone tracer uptake in SPECT/CT.
    Ann Nucl Med. 2019 Jan 3. pii: 10.1007/s12149-018-01324.
    PubMed     Abstract available


  236. YI C, Shi X, Zhang X, Luo G, et al
    The role of (13)N-ammonia in the differential diagnosis of gliomas and brain inflammatory lesions.
    Ann Nucl Med. 2019;33:61-67.
    PubMed     Abstract available


  237. NAKAMOTO Y, Ishimori T, Sano K, Shimizu Y, et al
    Clinical feasibility of early scanning after administration of (68)Ga-DOTATOC.
    Ann Nucl Med. 2019;33:55-60.
    PubMed     Abstract available


    December 2018
  238. TARALLI S, Lorusso M, Scolozzi V, Masiello V, et al
    Response evaluation with (18)F-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice.
    Ann Nucl Med. 2018 Dec 19. pii: 10.1007/s12149-018-01323.
    PubMed     Abstract available


  239. CASPERSEN KB, Giannoutsou N, Gerke O, Alavi A, et al
    Clinical value of (18)F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer.
    Ann Nucl Med. 2018 Dec 19. pii: 10.1007/s12149-018-01322.
    PubMed     Abstract available


  240. KOUKOURAKI SI, Hatzidakis AA, Mitrouska I, Stathaki MI, et al
    Does lung perfusion scintigraphy continue to have a role in the clinical management of patients suspected of pulmonary embolism in the CT pulmonary angiography era?
    Ann Nucl Med. 2018;32:709-714.
    PubMed     Abstract available


  241. SARIKAYA I, Sharma P, Sarikaya A
    F-18 fluoride uptake in primary breast cancer.
    Ann Nucl Med. 2018;32:678-686.
    PubMed     Abstract available


  242. TAKAHASHI A, Baba S, Sasaki M
    Assessment of collimators in radium-223 imaging with channelized Hotelling observer: a simulation study.
    Ann Nucl Med. 2018;32:649-657.
    PubMed     Abstract available


    November 2018
  243. FUJIWARA T, Hidaka K, Sugibayashi K, Matsumoto M, et al
    Investigation of the relation between administered dose and image quality for pediatric (99m)Tc-DMSA renal scintigraphy: clinical study applying the JSNM (Japanese Society of Nuclear Medicine) pediatric dosage card : The Japanese Society of Nuclear Me
    Ann Nucl Med. 2018 Nov 27. pii: 10.1007/s12149-018-1320.
    PubMed     Abstract available


  244. INOUE Y, Nagahara K, Inoki Y, Hara T, et al
    Clinical evaluation of CT radiation dose in whole-body (18)F-FDG PET/CT in relation to scout imaging direction and arm position.
    Ann Nucl Med. 2018 Nov 10. pii: 10.1007/s12149-018-1318.
    PubMed     Abstract available


  245. JORAKU A, Hatano K, Kawai K, Kandori S, et al
    Phase I/IIa PET imaging study with (89)zirconium labeled anti-PSMA minibody for urological malignancies.
    Ann Nucl Med. 2018 Nov 7. pii: 10.1007/s12149-018-1312.
    PubMed     Abstract available


  246. ZHENG S, Chen Z, Huang C, Chen Y, et al
    [(99m)Tc]3PRGD2 for integrin receptor imaging of esophageal cancer: a comparative study with [(18)F]FDG PET/CT.
    Ann Nucl Med. 2018 Nov 3. pii: 10.1007/s12149-018-1315.
    PubMed     Abstract available


  247. KAMEYAMA M, Watanabe K
    A new non-invasive graphical method for quantification of cerebral blood flow with[[Formula: see text]] IMP.
    Ann Nucl Med. 2018;32:620-626.
    PubMed     Abstract available


  248. TAKAMI Y, Yamamoto Y, Ueno M, Chiba Y, et al
    Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas.
    Ann Nucl Med. 2018;32:634-641.
    PubMed     Abstract available


  249. SETTA K, Kojima D, Shimada Y, Yoshida J, et al
    Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.
    Ann Nucl Med. 2018;32:611-619.
    PubMed     Abstract available


  250. USMANI S, Van den Wyngaert T, Ahmed N, Marafi F, et al
    Technical feasibility, radiation dosimetry and clinical use of (18)F-sodium fluoride (NaF) in evaluation of metastatic bone disease in pediatric population.
    Ann Nucl Med. 2018;32:594-601.
    PubMed     Abstract available


    October 2018
  251. TADESSE GF, Geramifar P, Tegaw EM, Ay MR, et al
    Techniques for generating attenuation map using cardiac SPECT emission data only: a systematic review.
    Ann Nucl Med. 2018 Oct 22. pii: 10.1007/s12149-018-1311.
    PubMed     Abstract available


  252. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Characteristics of iodine-123 IQ-SPECT/CT imaging compared with conventional SPECT/CT.
    Ann Nucl Med. 2018 Oct 15. pii: 10.1007/s12149-018-1310.
    PubMed     Abstract available


  253. KOH YW, Lee SJ, Park SY
    (18)F-fluorodeoxyglucose positron emission tomography is correlated with the pathological necrosis and decreased microvessel density in lung adenocarcinomas.
    Ann Nucl Med. 2018 Oct 15. pii: 10.1007/s12149-018-1309.
    PubMed     Abstract available


  254. SHIBUTANI T, Nakajima K, Wakabayashi H, Mori H, et al
    Accuracy of an artificial neural network for detecting a regional abnormality in myocardial perfusion SPECT.
    Ann Nucl Med. 2018 Oct 9. pii: 10.1007/s12149-018-1306.
    PubMed     Abstract available


  255. SASAMORI H, Uno K, Wu J
    Usefulness of both PET/CT with F18-FDG and whole-body diffusion-weighted imaging in cancer screening: a preliminary report.
    Ann Nucl Med. 2018 Oct 8. pii: 10.1007/s12149-018-1307.
    PubMed     Abstract available


  256. BRUMBERG J, Tran-Gia J, Lapa C, Isaias IU, et al
    PET imaging of noradrenaline transporters in Parkinson's disease: focus on scan time.
    Ann Nucl Med. 2018 Oct 6. pii: 10.1007/s12149-018-1305.
    PubMed     Abstract available


  257. RAHMAN MGM, Islam MM, Tsujikawa T, Kiyono Y, et al
    Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
    Ann Nucl Med. 2018 Oct 1. pii: 10.1007/s12149-018-1297.
    PubMed     Abstract available


    September 2018
  258. INUBUSHI M, Tatsumi M, Yamamoto Y, Kato K, et al
    European research trends in nuclear medicine.
    Ann Nucl Med. 2018 Sep 21. pii: 10.1007/s12149-018-1303.
    PubMed     Abstract available


  259. PALARD-NOVELLO X, Beuzit L, Gambarota G, Le Jeune F, et al
    Comparison of (18)F-Choline PET/CT and MRI functional parameters in prostate cancer.
    Ann Nucl Med. 2018 Sep 15. pii: 10.1007/s12149-018-1302.
    PubMed     Abstract available


  260. ANWAR H, Vogl TJ, Abougabal MA, Grunwald F, et al
    The value of different (18)F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients.
    Ann Nucl Med. 2018 Sep 15. pii: 10.1007/s12149-018-1301.
    PubMed     Abstract available


  261. LV N, Gao S, Bai L, Ji B, et al
    Advantages of (99m)Tc-3PRGD2 SPECT over CT in the preoperative assessment of lymph node metastasis in patients with esophageal cancer.
    Ann Nucl Med. 2018 Sep 14. pii: 10.1007/s12149-018-1300.
    PubMed     Abstract available


  262. XU J, Li Y, Hu S, Lu L, et al
    The significant value of predicting prognosis in patients with colorectal cancer using (18)F-FDG PET metabolic parameters of primary tumors and hematological parameters.
    Ann Nucl Med. 2018 Sep 14. pii: 10.1007/s12149-018-1299.
    PubMed     Abstract available


  263. KITAO T, Shiga T, Hirata K, Sekizawa M, et al
    Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
    Ann Nucl Med. 2018 Sep 8. pii: 10.1007/s12149-018-1298.
    PubMed     Abstract available


  264. BESHR R, Isohashi K, Watabe T, Naka S, et al
    Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [(18)F]fluoro-borono-phenylalanine PET/CT.
    Ann Nucl Med. 2018 Sep 7. pii: 10.1007/s12149-018-1296.
    PubMed     Abstract available


  265. INOUE Y, Hara T, Ikari T, Takahashi K, et al
    Super-early images of brain perfusion SPECT using (123)I-IMP for the assessment of hyperperfusion in stroke patients.
    Ann Nucl Med. 2018 Sep 1. pii: 10.1007/s12149-018-1293.
    PubMed     Abstract available


    August 2018
  266. VALOTASSIOU V, Malamitsi J, Papatriantafyllou J, Dardiotis E, et al
    SPECT and PET imaging in Alzheimer's disease.
    Ann Nucl Med. 2018 Aug 20. pii: 10.1007/s12149-018-1292.
    PubMed     Abstract available


  267. NAKANISHI Y, Kitajima K, Yamada Y, Hashimoto T, et al
    Diagnostic performance of (11)C-choline PET/CT and FDG PET/CT for staging and restaging of renal cell cancer.
    Ann Nucl Med. 2018 Aug 17. pii: 10.1007/s12149-018-1287.
    PubMed     Abstract available


  268. HAN S, Kim H, Kim YJ, Suh CH, et al
    Prognostic value of volume-based metabolic parameters of (18)F-FDG PET/CT in ovarian cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2018 Aug 12. pii: 10.1007/s12149-018-1289.
    PubMed     Abstract available


  269. YOO J, Kim BS, Yoon HJ
    Predictive value of primary tumor parameters using (18)F-FDG PET/CT for occult lymph node metastasis in breast cancer with clinically negative axillary lymph node.
    Ann Nucl Med. 2018 Aug 9. pii: 10.1007/s12149-018-1288.
    PubMed     Abstract available


  270. SEIDER MJ, Pugh SL, Langer C, Wyatt G, et al
    Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial.
    Ann Nucl Med. 2018 Aug 9. pii: 10.1007/s12149-018-1278.
    PubMed     Abstract available


  271. ISHIWATA K, Ebinuma R, Watanabe C, Hayashi K, et al
    Reliable radiosynthesis of 4-[(10)B]borono-2-[(18)F]fluoro-L-phenylalanine with quality assurance for boron neutron capture therapy-oriented diagnosis.
    Ann Nucl Med. 2018;32:463-473.
    PubMed     Abstract available


  272. KATSUURA T, Kitajima K, Fujiwara M, Terada T, et al
    Assessment of tumor response to chemoradiotherapy and predicting prognosis in patients with head and neck squamous cell carcinoma by PERCIST.
    Ann Nucl Med. 2018;32:453-462.
    PubMed     Abstract available


  273. MAIR C, Warwitz B, Fink K, Scarpa L, et al
    Radiation exposure after (177)Lu-DOTATATE and (177)Lu-PSMA-617 therapy.
    Ann Nucl Med. 2018;32:499-502.
    PubMed     Abstract available


  274. PAK K, Nam HY, Shin S, Kim K, et al
    Effects of rs591323 on serotonin transporter availability in healthy male subjects.
    Ann Nucl Med. 2018;32:431-436.
    PubMed     Abstract available


    July 2018
  275. MITAMURA K, Yamamoto Y, Norikane T, Hatakeyama T, et al
    Correlation of (18)F-FDG and (11)C-methionine uptake on PET/CT with Ki-67 immunohistochemistry in newly diagnosed intracranial meningiomas.
    Ann Nucl Med. 2018 Jul 21. pii: 10.1007/s12149-018-1284.
    PubMed     Abstract available


  276. HAN S, Woo S, Suh CH, Kim YJ, et al
    A systematic review of the prognostic value of texture analysis in (18)F-FDG PET in lung cancer.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1281.
    PubMed     Abstract available


  277. HIGASHIYAMA A, Komori T, Juri H, Inada Y, et al
    Detectability of residual invasive bladder cancer in delayed (18)F-FDG PET imaging with oral hydration using 500 mL of water and voiding-refilling.
    Ann Nucl Med. 2018 Jul 16. pii: 10.1007/s12149-018-1280.
    PubMed     Abstract available


  278. KOMEK H, Can C, Yilmaz U, Altindag S, et al
    Prognostic value of 68 Ga PSMA I&T PET/CT SUV parameters on survival outcome in advanced prostat cancer.
    Ann Nucl Med. 2018 Jul 13. pii: 10.1007/s12149-018-1277.
    PubMed     Abstract available


  279. ALBANO D, Bertoli M, Battistotti M, Rodella C, et al
    Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
    Ann Nucl Med. 2018 Jul 7. pii: 10.1007/s12149-018-1274.
    PubMed     Abstract available


  280. RINGHEIM A, Campos Neto GC, Martins KM, Vitor T, et al
    Reproducibility of standardized uptake values of same-day randomized (68)Ga-PSMA-11 PET/CT and PET/MR scans in recurrent prostate cancer patients.
    Ann Nucl Med. 2018 Jul 7. pii: 10.1007/s12149-018-1275.
    PubMed     Abstract available


  281. LEE SH, Sung C, Lee HS, Yoon HY, et al
    Is (18)F-FDG PET/CT useful for the differential diagnosis of solitary pulmonary nodules in patients with idiopathic pulmonary fibrosis?
    Ann Nucl Med. 2018 Jul 4. pii: 10.1007/s12149-018-1273.
    PubMed     Abstract available


  282. KURISU S, Nitta K, Sumimoto Y, Ikenaga H, et al
    Implications of electrocardiographic frontal QRS axis on left ventricular diastolic parameters derived from electrocardiogram-gated myocardial perfusion single photon emission computed tomography.
    Ann Nucl Med. 2018;32:404-409.
    PubMed     Abstract available


  283. TEMMA T, Kondo N, Yoda K, Nishigori K, et al
    Comparison of (125)I- and (111)In-labeled peptide probes for in vivo detection of oxidized low-density lipoprotein in atherosclerotic plaques.
    Ann Nucl Med. 2018;32:425-429.
    PubMed     Abstract available


    June 2018
  284. AOE J, Watabe T, Shimosegawa E, Kato H, et al
    Evaluation of the default-mode network by quantitative (15)O-PET: comparative study between cerebral blood flow and oxygen consumption.
    Ann Nucl Med. 2018 Jun 22. pii: 10.1007/s12149-018-1272.
    PubMed     Abstract available


  285. HEMMATI H, Kamali-Asl A, Ghafarian P, Ay MR, et al
    Reconstruction/segmentation of attenuation map in TOF-PET based on mixture models.
    Ann Nucl Med. 2018 Jun 21. pii: 10.1007/s12149-018-1270.
    PubMed     Abstract available


  286. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    Publisher Correction to: (18)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1271.
    PubMed     Abstract available


  287. XU J, Li Y, Xu X, Zhang J, et al
    Clinical application of (99m)Tc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1266.
    PubMed     Abstract available


  288. YUGE S, Nakatani K, Yoshino K, Koyama T, et al
    Diagnosing polymyalgia rheumatica on (18)F-FDG PET/CT: typical uptake patterns.
    Ann Nucl Med. 2018 Jun 8. pii: 10.1007/s12149-018-1269.
    PubMed     Abstract available


  289. MOLINA-GARCIA D, Garcia-Vicente AM, Perez-Beteta J, Amo-Salas M, et al
    Intratumoral heterogeneity in (18)F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate.
    Ann Nucl Med. 2018 Jun 5. pii: 10.1007/s12149-018-1253.
    PubMed     Abstract available


  290. LEBASNIER A, Legallois D, Bienvenu B, Bergot E, et al
    Diagnostic value of quantitative assessment of cardiac (18)F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Ann Nucl Med. 2018;32:319-327.
    PubMed     Abstract available


  291. YOO J, Kim BS, Yoon HJ
    Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.
    Ann Nucl Med. 2018;32:328-336.
    PubMed     Abstract available


  292. NAKAJIMA K, Okuda K, Watanabe S, Matsuo S, et al
    Artificial neural network retrained to detect myocardial ischemia using a Japanese multicenter database.
    Ann Nucl Med. 2018;32:303-310.
    PubMed     Abstract available


    May 2018
  293. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Correction to: Predictive and prognostic value of (18)F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2018 May 24. pii: 10.1007/s12149-018-1265.
    PubMed     Abstract available


  294. CHOI JH, Lim I, Noh WC, Kim HA, et al
    Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1259.
    PubMed     Abstract available


  295. KAMEI R, Watanabe Y, Sagiyama K, Isoda T, et al
    Optimal monochromatic color combinations for fusion imaging of FDG-PET and diffusion-weighted MR images.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1263.
    PubMed     Abstract available


  296. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    (718)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 May 12. pii: 10.1007/s12149-018-1260.
    PubMed     Abstract available


  297. SAUERBECK J, Ishii K, Hosokawa C, Kaida H, et al
    The correlation between striatal and cortical binding ratio of (11)C-PiB-PET in amyloid-uptake-positive patients.
    Ann Nucl Med. 2018 May 5. pii: 10.1007/s12149-018-1258.
    PubMed     Abstract available


  298. LIU S, Gu B, Zhang J, Zhang Y, et al
    The feasibility of (18)F-FES and (18)F-FDG microPET/CT for early monitoring the effect of fulvestrant on sensitizing docetaxel by downregulating ERalpha in ERalpha+ breast cancer.
    Ann Nucl Med. 2018;32:272-280.
    PubMed     Abstract available


    April 2018
  299. ISHIGUCHI H, Ito S, Kato K, Sakurai Y, et al
    Diagnostic performance of (18)F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ann Nucl Med. 2018 Apr 17. pii: 10.1007/s12149-018-1254.
    PubMed     Abstract available


  300. IWABUCHI Y, Nakahara T, Kameyama M, Yamada Y, et al
    Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation.
    Ann Nucl Med. 2018 Apr 13. pii: 10.1007/s12149-018-1256.
    PubMed     Abstract available


  301. WATANABE M, Nakamoto Y, Koyasu S, Ishimori T, et al
    The influence of elevated hormone levels on physiologic accumulation of (68)Ga-DOTATOC.
    Ann Nucl Med. 2018;32:191-196.
    PubMed     Abstract available


  302. HOSONO M, Ikebuchi H, Nakamura Y, Nakamura N, et al
    Manual on the proper use of lutetium-177-labeled somatostatin analogue (Lu-177-DOTA-TATE) injectable in radionuclide therapy (2nd ed.).
    Ann Nucl Med. 2018;32:217-235.
    PubMed     Abstract available


    March 2018
  303. BEXELIUS T, Sohlberg A
    Implementation of GPU accelerated SPECT reconstruction with Monte Carlo-based scatter correction.
    Ann Nucl Med. 2018 Mar 21. pii: 10.1007/s12149-018-1252.
    PubMed     Abstract available


  304. INUI Y, Ichihara T, Uno M, Ishiguro M, et al
    CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study.
    Ann Nucl Med. 2018 Mar 19. pii: 10.1007/s12149-018-1248.
    PubMed     Abstract available


  305. MIZUMURA S, Nishikawa K, Murata A, Yoshimura K, et al
    Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.
    Ann Nucl Med. 2018 Mar 15. pii: 10.1007/s12149-018-1249.
    PubMed     Abstract available


    February 2018
  306. PALARD-NOVELLO X, Blin AL, Bourhis D, Garin E, et al
    Comparison of choline influx from dynamic (18)F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment.
    Ann Nucl Med. 2018 Feb 28. pii: 10.1007/s12149-018-1246.
    PubMed     Abstract available


  307. TSUJIKAWA T, Narita N, Kanno M, Takabayashi T, et al
    Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
    Ann Nucl Med. 2018 Feb 27. pii: 10.1007/s12149-018-1244.
    PubMed     Abstract available


  308. SIMSEK DH, Sanli Y, Kuyumcu S, Basaran B, et al
    (68)Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.
    Ann Nucl Med. 2018 Feb 21. pii: 10.1007/s12149-018-1242.
    PubMed     Abstract available


  309. ANNUNZIATA S, Cuccaro A, Tisi MC, Hohaus S, et al
    FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Ann Nucl Med. 2018 Feb 20. pii: 10.1007/s12149-018-1243.
    PubMed     Abstract available


  310. NISHII R, Higashi T, Kagawa S, Okuyama C, et al
    (18)F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man (18)F-FPYBF-2 PET imaging.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1240.
    PubMed     Abstract available


  311. TORIIHARA A, Ohtake M, Tateishi K, Hino-Shishikura A, et al
    Prognostic implications of (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET/CT in patients with glioma.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1241.
    PubMed     Abstract available


  312. OZDERYA A, Temizkan S, Gul AE, Ozugur S, et al
    Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism.
    Ann Nucl Med. 2018 Feb 5. pii: 10.1007/s12149-018-1239.
    PubMed     Abstract available


  313. HABERT MO, Bertin H, Labit M, Diallo M, et al
    Evaluation of amyloid status in a cohort of elderly individuals with memory complaints: validation of the method of quantification and determination of positivity thresholds.
    Ann Nucl Med. 2018;32:75-86.
    PubMed     Abstract available


    January 2018
  314. HIGASHI T, Nishii R, Kagawa S, Kishibe Y, et al
    (18)F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.
    Ann Nucl Med. 2018 Jan 31. pii: 10.1007/s12149-018-1236.
    PubMed     Abstract available


  315. DONG W, Li J, Mi H, Song X, et al
    Relationship between collateral circulation and myocardial viability of (18)F-FDG PET/CT subtended by chronic total occluded coronary arteries.
    Ann Nucl Med. 2018 Jan 29. pii: 10.1007/s12149-018-1234.
    PubMed     Abstract available


  316. TSUJIMOTO M, Teramoto A, Ota S, Toyama H, et al
    Automated segmentation and detection of increased uptake regions in bone scintigraphy using SPECT/CT images.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1237.
    PubMed     Abstract available


  317. ARORA G, Bandopadhyaya G
    Paradigm shift in theranostics of neuroendocrine tumors: conceptual horizons of nanotechnology in nuclear medicine.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1235.
    PubMed     Abstract available


  318. NAKAJIMA K, Okuda K, Matsuo S, Wakabayashi H, et al
    Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.
    Ann Nucl Med. 2018 Jan 15. pii: 10.1007/s12149-018-1231.
    PubMed     Abstract available


  319. GERBAUDO VH, Killoran JH, Kim CK, Hornick JL, et al
    Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
    Ann Nucl Med. 2018 Jan 13. pii: 10.1007/s12149-018-1229.
    PubMed     Abstract available


  320. KARTAMIHARDJA AHS, Kurniawati Y, Gunawan R
    Diagnostic value of (99m)Tc-ethambutol scintigraphy in tuberculosis: compared to microbiological and histopathological tests.
    Ann Nucl Med. 2018;32:60-68.
    PubMed     Abstract available


    December 2017
  321. KITS A, Martin H, Sanchez-Crespo A, Delgado AF, et al
    Diagnostic accuracy of (11)C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy.
    Ann Nucl Med. 2017 Dec 26. pii: 10.1007/s12149-017-1227.
    PubMed     Abstract available


  322. GARCIA-VICENTE AM, Tello-Galan MJ, Amo-Salas M, Ros-Izquierdo J, et al
    Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?
    Ann Nucl Med. 2017 Dec 20. pii: 10.1007/s12149-017-1226.
    PubMed     Abstract available


  323. UMEDA T, Koizumi M, Fukai S, Miyaji N, et al
    Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Ann Nucl Med. 2017 Dec 14. pii: 10.1007/s12149-017-1224.
    PubMed     Abstract available


  324. CHEIMARIOTIS GA, Al-Mashat M, Haris K, Aletras AH, et al
    Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CT.
    Ann Nucl Med. 2017 Dec 13. pii: 10.1007/s12149-017-1223.
    PubMed     Abstract available


  325. JONES KM, Solnes LB, Rowe SP, Gorin MA, et al
    Use of quantitative SPECT/CT reconstruction in (99m)Tc-sestamibi imaging of patients with renal masses.
    Ann Nucl Med. 2017 Dec 6. pii: 10.1007/s12149-017-1222.
    PubMed     Abstract available


    November 2017
  326. SATHEKGE M, Garcia-Perez O, Paez D, El-Haj N, et al
    Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT.
    Ann Nucl Med. 2017 Nov 21. doi: 10.1007/s12149-017-1219.
    PubMed     Abstract available


  327. LI T, Wu NY, Song N, Mok GSP, et al
    Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry.
    Ann Nucl Med. 2017 Nov 15. doi: 10.1007/s12149-017-1218.
    PubMed     Abstract available


  328. KITAJIMA K, Miyoshi Y, Yamano T, Odawara S, et al
    Prognostic value of FDG-PET and DWI in breast cancer.
    Ann Nucl Med. 2017 Nov 13. doi: 10.1007/s12149-017-1217.
    PubMed     Abstract available


  329. SANLI Y, Kuyumcu S, Sanli O, Buyukkaya F, et al
    Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Ann Nucl Med. 2017;31:709-717.
    PubMed     Abstract available


  330. KURISU S, Sumimoto Y, Ikenaga H, Ishibashi K, et al
    Effects of chronic kidney disease on myocardial washout rate of thallium-201 in patients with normal myocardial perfusion on single photon emission computed tomography.
    Ann Nucl Med. 2017;31:703-708.
    PubMed     Abstract available


  331. WERNER RA, Sheikhbahaei S, Jones KM, Javadi MS, et al
    Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.
    Ann Nucl Med. 2017;31:696-702.
    PubMed     Abstract available


    October 2017
  332. CAMPBELL SP, Baras AS, Ball MW, Kates M, et al
    Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma.
    Ann Nucl Med. 2017 Oct 24. doi: 10.1007/s12149-017-1216.
    PubMed     Abstract available


  333. AMAKUSA S, Matsuoka K, Kawano M, Hasegawa K, et al
    Influence of region-of-interest determination on measurement of signal-to-noise ratio in liver on PET images.
    Ann Nucl Med. 2017 Oct 20. doi: 10.1007/s12149-017-1215.
    PubMed     Abstract available


  334. KIRIYAMA T, Fukushima Y, Hayashi H, Takano H, et al
    Feasibility of combined risk stratification with coronary CT angiography and stress myocardial SPECT in patients with chronic coronary artery disease.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1214.
    PubMed     Abstract available


  335. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1213.
    PubMed     Abstract available


  336. MASAKI Y, Shimizu Y, Yoshioka T, Nishijima KI, et al
    FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
    Ann Nucl Med. 2017;31:596-604.
    PubMed     Abstract available


    September 2017
  337. NAKAJIMA K, Okuda K, Momose M, Matsuo S, et al
    IQ.SPECT technology and its clinical applications using multicenter normal databases.
    Ann Nucl Med. 2017 Sep 22. doi: 10.1007/s12149-017-1210.
    PubMed     Abstract available


  338. KROISS AS, Nekolla SG, Dobrozemsky G, Grubinger T, et al
    CT-based SPECT attenuation correction and assessment of infarct size: results from a cardiac phantom study.
    Ann Nucl Med. 2017 Sep 21. doi: 10.1007/s12149-017-1211.
    PubMed     Abstract available


  339. OKIZAKI A, Nakayama M, Nakajima K, Katayama T, et al
    Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.
    Ann Nucl Med. 2017 Sep 14. doi: 10.1007/s12149-017-1209.
    PubMed     Abstract available


  340. TSUJIKAWA T, Yamamoto M, Shono K, Yamada S, et al
    Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an 18F-FDG PET/CT texture analysis.
    Ann Nucl Med. 2017 Sep 13. doi: 10.1007/s12149-017-1208.
    PubMed     Abstract available


  341. GARCIA-VICENTE AM, Molina D, Perez-Beteta J, Amo-Salas M, et al
    Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
    Ann Nucl Med. 2017 Sep 8. doi: 10.1007/s12149-017-1203.
    PubMed     Abstract available


  342. SUGIHARA T, Koizumi M, Koyama M, Terauchi T, et al
    Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
    Ann Nucl Med. 2017 Sep 1. doi: 10.1007/s12149-017-1202.
    PubMed     Abstract available


    August 2017
  343. TSUJIKAWA T, Rahman T, Yamamoto M, Yamada S, et al
    18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1199.
    PubMed     Abstract available


  344. YAMASHITA S, Yamamoto H, Nakaichi T, Yoneyama T, et al
    Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body 18F-fluorodeoxyglucose positron emission tomography with the same acquisition duration.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1200.
    PubMed     Abstract available


  345. YADA N, Onishi H, Miyai M, Ozasa K, et al
    Effect of resolution recovery using graph plots on regional cerebral blood flow in healthy volunteers.
    Ann Nucl Med. 2017;31:553-562.
    PubMed     Abstract available


    July 2017
  346. CHEN L, Tsui BMW, Mok GSP
    Design and evaluation of two multi-pinhole collimators for brain SPECT.
    Ann Nucl Med. 2017 Jul 28. doi: 10.1007/s12149-017-1195.
    PubMed     Abstract available


  347. INUBUSHI M, Kaneta T, Ishimori T, Imabayashi E, et al
    Topics of nuclear medicine research in Europe.
    Ann Nucl Med. 2017 Jul 25. doi: 10.1007/s12149-017-1198.
    PubMed     Abstract available


  348. ISIK EG, Kuyumcu S, Kebudi R, Sanli Y, et al
    Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to DeltaSUVmax, Deauville 5-point scale and IHP criteria.
    Ann Nucl Med. 2017 Jul 24. doi: 10.1007/s12149-017-1196.
    PubMed     Abstract available


  349. ITO S, Endo A, Okada T, Nakamura T, et al
    Comparison of CTAC and prone imaging for the detection of coronary artery disease using CZT SPECT.
    Ann Nucl Med. 2017 Jul 10. doi: 10.1007/s12149-017-1194.
    PubMed     Abstract available


  350. HOWARD BA, Morgan R, Thorpe MP, Turkington TG, et al
    Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1192.
    PubMed     Abstract available


  351. NAKAJIMA K, Okuda K, Yokoyama K, Yoneyama T, et al
    Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1191.
    PubMed     Abstract available


  352. SANTHOSH S, Mittal BR, Bhasin DK, Rana SS, et al
    Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1193.
    PubMed     Abstract available


  353. HIGASHI K, Ueda Y, Shimasaki M, Ishigaki Y, et al
    High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
    Ann Nucl Med. 2017 Jul 4. doi: 10.1007/s12149-017-1187.
    PubMed     Abstract available


  354. ZHENG J, Miao W, Huang C, Lin H, et al
    Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging.
    Ann Nucl Med. 2017;31:486-494.
    PubMed     Abstract available


    June 2017
  355. CHENG L, Zhang J, Wang Y, Xu X, et al
    Textural features of 18F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer.
    Ann Nucl Med. 2017 Jun 23. doi: 10.1007/s12149-017-1184.
    PubMed     Abstract available


  356. SHIDAHARA M, Thomas BA, Okamura N, Ibaraki M, et al
    A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.
    Ann Nucl Med. 2017 Jun 21. doi: 10.1007/s12149-017-1185.
    PubMed     Abstract available


  357. NIKAKI A, Angelidis G, Efthimiadou R, Tsougos I, et al
    18F-fluorothymidine PET imaging in gliomas: an update.
    Ann Nucl Med. 2017 Jun 13. doi: 10.1007/s12149-017-1183.
    PubMed     Abstract available


  358. ISHIBASHI M, Tanabe Y, Fujii S, Ogawa T, et al
    Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesions.
    Ann Nucl Med. 2017 Jun 5. doi: 10.1007/s12149-017-1182.
    PubMed     Abstract available


  359. KATAGIRI M, Nakahara T, Murata M, Ogata Y, et al
    Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy.
    Ann Nucl Med. 2017;31:399-406.
    PubMed     Abstract available


  360. SHIMIZU S, Hirose D, Namioka N, Kanetaka H, et al
    Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.
    Ann Nucl Med. 2017;31:390-398.
    PubMed     Abstract available


  361. KUNIKOWSKA J, Pawlak D, Bak MI, Kos-Kudla B, et al
    Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.
    Ann Nucl Med. 2017;31:347-356.
    PubMed     Abstract available


    May 2017
  362. IMABAYASHI E, Soma T, Sone D, Tsukamoto T, et al
    Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Ann Nucl Med. 2017 May 25. doi: 10.1007/s12149-017-1181.
    PubMed     Abstract available


  363. AKTAN M, Koc M, Kanyilmaz G, Yavuz BB, et al
    Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer.
    Ann Nucl Med. 2017 May 17. doi: 10.1007/s12149-017-1178.
    PubMed     Abstract available


  364. KIM JW, Seo S, Kim HS, Kim DY, et al
    Erratum to: Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1179.
    PubMed    


  365. TORIIHARA A, Nakajima R, Arai A, Nakadate M, et al
    Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1180.
    PubMed     Abstract available


  366. SUZUKI H, Kato K, Nishio M, Tamaki T, et al
    FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1176.
    PubMed     Abstract available


  367. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Characteristics of single- and dual-photopeak energy window acquisitions with thallium-201 IQ-SPECT/CT system.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1177.
    PubMed     Abstract available


  368. SADEGHZADEH M, Alirezapour B, Charkhlooie GA, Baghery MK, et al
    Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine as a breast tumor imaging tracer in mouse.
    Ann Nucl Med. 2017;31:335-346.
    PubMed     Abstract available


  369. MOSLEMI V, Ashoor M
    Design and performance evaluation of a new high energy parallel hole collimator for radioiodine planar imaging by gamma cameras: Monte Carlo simulation study.
    Ann Nucl Med. 2017;31:324-334.
    PubMed     Abstract available


    April 2017
  370. KOIZUMI M, Motegi K, Koyama M, Terauchi T, et al
    Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
    Ann Nucl Med. 2017 Apr 29. doi: 10.1007/s12149-017-1175.
    PubMed     Abstract available


  371. WENG CC, Huang SL, Chen ZA, Lin KJ, et al
    [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.
    Ann Nucl Med. 2017 Apr 27. doi: 10.1007/s12149-017-1174.
    PubMed     Abstract available


  372. KIM JW, Seo S, Kim HS, Kim DY, et al
    Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 Apr 25. doi: 10.1007/s12149-017-1171.
    PubMed     Abstract available


  373. WATABE T, Hanaoka K, Naka S, Kanai Y, et al
    Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET.
    Ann Nucl Med. 2017 Apr 24. doi: 10.1007/s12149-017-1172.
    PubMed     Abstract available


  374. KONISHI T, Nakajima K, Okuda K, Yoneyama H, et al
    IQ-SPECT for thallium-201 myocardial perfusion imaging: effect of normal databases on quantification.
    Ann Nucl Med. 2017 Apr 12. doi: 10.1007/s12149-017-1170.
    PubMed     Abstract available


  375. YAMAMOTO H, Arimura S, Nakanishi A, Shimo Y, et al
    Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT.
    Ann Nucl Med. 2017 Apr 5. doi: 10.1007/s12149-017-1168.
    PubMed     Abstract available


  376. HASHIMOTO T, Yokota C, Koshino K, Temma T, et al
    Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease.
    Ann Nucl Med. 2017;31:227-234.
    PubMed     Abstract available


  377. KURISU S, Higaki T, Sumimoto Y, Ikenaga H, et al
    Aortic knob width reflects left ventricular diastolic function assessed by gated myocardial perfusion single photon emission computed tomography in patients with normal myocardial perfusion.
    Ann Nucl Med. 2017;31:245-249.
    PubMed     Abstract available


  378. GENDRE R, Lairez O, Mondoly P, Duparc A, et al
    Research of predictive factors for cardiac resynchronization therapy: a prospective study comparing data from phase-analysis of gated myocardial perfusion single-photon computed tomography and echocardiography : Trying to anticipate response to CRT.
    Ann Nucl Med. 2017;31:218-226.
    PubMed     Abstract available


  379. MIKI T, Shimada H, Kim JS, Yamamoto Y, et al
    Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
    Ann Nucl Med. 2017;31:260-272.
    PubMed     Abstract available


  380. MISAKA T, Hosono M, Kudo T, Ito T, et al
    Influence of acquisition orbit on phase analysis of gated single photon emission computed tomography myocardial perfusion imaging for assessment of left ventricular mechanical dyssynchrony.
    Ann Nucl Med. 2017;31:235-244.
    PubMed     Abstract available


  381. WATANABE S, Nakajima K, Mizokami A, Yaegashi H, et al
    Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Ann Nucl Med. 2017;31:201-210.
    PubMed     Abstract available


    March 2017
  382. SINGNURKAR A, Poon R, Metser U
    Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.
    Ann Nucl Med. 2017 Mar 28. doi: 10.1007/s12149-017-1164.
    PubMed     Abstract available


  383. KROISS AS, Uprimny C, Shulkin BL, Frech A, et al
    Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.
    Ann Nucl Med. 2017 Mar 27. doi: 10.1007/s12149-017-1162.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: